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Abstract 
 
The role of the benign microenvironment in the primary tumor has recently come into 
focus. In particular, research has shown that blood-derived macrophages may support 
tumor progression. By contrast, the role of resident macrophages in metastatic organs, 
has barely been investigated, especially in brain metastases. Because of the severe 
therapeutic problems posed by brain metastasis, we focused on the role of microglia in 
this process. To better study the direct interaction between carcinoma cells and living 
brain tissue, we developed a new coculture model combining an organotypic mouse brain 
slice with an adjacent tumor cell deposit. We showed that microglia enhance invasion 
and colonization by breast cancer cells, serving as an active transporter and guiding rail. 
Proinvasive microglia exhibit an altered morphology, but do not exhibit up-regulation of 
M2-like activation-associated cytokines or differential gene expression. Bacterial 
lipopolysacharide (LPS), activating Toll-like receptor (TLR) 4 signaling, prompted a 
classical M1 phenotype in tumor-instructed microglia and reducing their proinvasive 
function. A comparable effect on tumor cell invasion may be achieved by inactivating 
microglia via clodronate or by inhibiting Wnt signaling either at the receptor level or at 
the Wnt downstream target, CXCR4. Importantly, we found that TLR (4) and nitric oxide 
(NO) signaling played an ambiguous role, depending on the involved TLR signaling 
pathways via the adaptor proteins MyD88 and TRIF.  While MyD88 signaling in 
microglia was required for tumor support, (additional) activation of the TRIF route could 
reverse the outcome. 
Taken together, our data revealed that microglial cells play a key role in tumor 
progression, with both Wnt and TLR signaling as well as certain common targets being 
critical elements in this process.  
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1. Introduction 
 
1.1 Metastasis and the role of the microenvironment 
 
Metastatic disease causes 90% of all cancer cell deaths. While surgery, chemotherapy 
and radiation can control many cancers at the primary site, once metastatic diseases 
develop, treatment is very limited and prognosis is poor (Hanahan and Weinberg, 2000). 
Approximately 20-30% of patients with primary tumors develop metastases to the brain 
(Fokas et al., 2007; Lassman and DeAngelis, 2003) and they are most commonly 
observed in patients with lung, breast or colorectal cancer. Patients with melanoma also 
suffer from brain metastases frequently. Cancer cells can thereby directly colonize the 
brain parenchyma or cause leptomeningeal spread, the latter being the most aggressive 
form of brain metastasis.  
 
1.1.1 Steps for metastasis and the impact of microenvironment 
 
Successful metastasis requires a series of discrete biological processes. Cancer cells 
spread outward from the primary site by invading the surrounding tissues, entering the 
lymphatic vessels or bloodstream. Afterwards, the cells arrest in the circulation, 
extravasate into the distant tissue and grow at this new location (colonization). 
Colonization at a distant site includes several features, i.e. tumor cell proliferation, 
apoptosis, dormancy and angiogenesis (Gupta and Massague, 2006; Steeg, 2006; Steeg 
and Theodorescu, 2008).  
In addition, the affected organs have their specific characteristics. In case of brain 
metastasis, cancer cells have to cross the blood brain barrier (BBB) and then penetrate a 
unique microenvironment. The BBB tightly regulates access of circulating molecules and 
cells to the central nervous system (CNS). It allows for selective entries but also imposes 
extremely restrictive exclusions. The BBB is so effective that most molecules cannot 
penetrate it unless carried across by transcellular transport. Several cell types, namely 
endothelial cells, astrocytes and pericytes, as well as a basement membrane contribute to 
the association with the BBB, tight junctions, transporters and pumps providing key 
features of selective barrier (Entschladen et al., 2005). In brain metastasis, however, this 
barrier is compromised and cancer cells are able to extravasate into the brain. If cancer 
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cells overcome this barrier, they then come into contact with glial cells. This can either 
lead to apoptosis and phagocytosis of the cancer cells or to a further facilitation of the 
metastatic process by triggering tumor cell motility with cytokines, chemokines, growth 
factors, neuropeptides or neurotransmitters (e.g., norepinephrine, dopamine, histamine, 
angiotensin and substance P) (Gupta and Massague, 2006; Steeg, 2006). 
 
 
 
Fig. 1.1.1: The process of tumor metastases. First, tumor cells invade the lymphatics or enter directly 
into the blood circulation. Second, in order for the cells to extravasate, they must survive in the blood 
stream and avoid attacks by the immune system. Arrest may involve adhesive interactions, but is mostly by 
size restriction in capillary beds. Third, cancer cells form micrometastases, followed by the establishment 
of vascularized macrometastases, at a site distant from the primary tumor. This process is called 
colonization. Tumor cells interact crucially with tissue cells in their new microenvironment, although there 
may be periods of dormancy at this stage (figure adapted from Steeg, 2006). 
 
Like the colonization phase, every stage of metastasis presents new obstacles for cancer 
cells, and the microenvironment plays a crucial role throughout the whole process. Even 
if the cells successfully emigrate from the primary tumor site, many of them will become 
apoptotic or quiescent, with relatively few becoming reactivated later and even less 
finally developing into metastases. The microenvironment—in particular the 
macrophages—seems to determine whether cancer cells will progress to the next step 
(Joyce and Pollard, 2009).  
 
 
 
  t  t st s s.  
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1.1.2 The seed and soil theory of metastatic dissemination 
 
Although a tumor may seed multiple organs, metastasis may only occur in some 
(Husemann et al., 2008). There is also evidence that cancer cell dormancy can last for 
years, meaning that seeding can take place years before a primary tumor is diagnosed 
(Joyce and Pollard, 2009). Therefore, colonization involves reciprocal interactions 
between tumor cells and their new tissue microenvironment, with different outcomes. 
Stephen Paget made this crucial observation in 1889 when he observed that breast cancer 
tended to metastasize to the liver. Paget hypothesized that some tumor cells act as 
―seeds,‖ colonizing only those distant organs, or ―soils,‖ with the right 
microenvironment. This was the foundation of the ―seed and soil‖ theory. In other words, 
certain organs provide the right conditions for colonization by certain cancers as 
originating in other organs (Fokas et al., 2007; Paget, 1989). Scores of studies prove this 
theory. It is now widely accepted that cancer progression depends on cues from 
surrounding tissues, rather than simply being a matter of genetic mutations causing 
uncontrolled cellular division (Fidler, 2003; Lee and Herlyn, 2007).  
 
1.2 Stromal cells, tumor-associated macrophages can aid either the 
immune system or tumor progression 
 
1.2.1 Stromal cells 
 
Carcinomas include epithelial tumor cells, extracellular matrix (ECM), blood vessel and 
benign cellular components, such as fibroblasts and immune cells (Mueller and Fusenig, 
2004). Various types of stromal cells are believed to play a role in metastasis: endothelial 
cells (the blood and lymphatic circulatory systems), pericytes, fibroblasts and bone 
marrow-derived cells (BMDCs), such as macrophages, neutrophils, mast cells, dendritic 
cells and mesenchymal stem cells. BMDCs can facilitate angiogenesis by producing 
growth factors, cytokines and proteases, such as vascular endothelial growth factor A 
(VEGFA), prokineticin 2 (PROK2) and matrix metalloproteinases (MMPs), respectively 
(Joyce and Pollard, 2009). Several studies have also shown that changes in the behavior 
of stromal cells can promote epithelial transformation (Liotta and Kohn, 2001) as well as 
matrix remodeling of adjacent tissue (Mantovani et al., 2008). Most notably, the 
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infiltration grade of macrophages correlates with poor prognosis in different tumors 
(Bingle et al., 2002). 
Macrophages can either hinder or facilitate tumor progression, depending on their 
functional state. Wyckoff and colleagues demonstrated that tumor-associated 
macrophages (TAMs) significantly increase tumor motility in the primary tumor site, and 
that the effect is enhanced when tumor cells are found adjacent to perivascular TAMs 
(Wyckoff et al., 2004). Others have also found that tumor cells co-migrate with TAMs 
through a stimulatory loop that includes colony stimulating factor-1 (CSF-1) and 
epidermal growth factor (EGF) (Goswami et al., 2005). It is generally believed that 
TAMs play an important role in the early stages of metastasis, including evasion and 
intravasation. However, whether macrophages are involved in the final step—the 
colonization of distant tissues—remains unclear. Depletion experiments targeting 
macrophages in animal models not only reduce the tumor size at the primary site but also 
influence metastasis. This indicates a pivotal role in carcinoma progression (Hiraga et al., 
2004; Robinson-Smith et al., 2007; Zeisberger et al., 2006). 
Macrophages are classified as either M1 or M2, depending on which T helper (TH) 
cell they are associated with: TH1 cells release cytokines that induce M1, while TH2 cells 
release cytokines that induce M2 (Mantovani et al., 2007). TAMs usually exhibit an M2-
like (also known as ―alternatively activated‖) phenotype, secreting immunosuppressive 
cytokines, such as interleukin (IL)-10 and the C-C motif chemokine 22 (CCL22), 
producing proangiogenic and tissue-remodeling factors, such as VEGFA and MMP9. In 
contrast to M2 macrophages, M1 (or ―classically activated‖) macrophages are induced by 
interferon γ (IFNγ), either alone or together with microbial stimuli (e.g., 
lipopolysaccharide, LPS) or other cytokines (e.g., tumor necrosis factor α, TNFα, and 
granulocyte macrophage colony-stimulating factor, GM-CSF).  In general, M1 cells have 
an IL-12
high
/IL-23
high
, IL-10
low
 phenotype (Mantovani et al., 2007). 
 
1.3. Microglia in the CNS 
 
Microglia are the resident macrophages of the brain and are considered the primary 
innate immune cells of the CNS (Hanisch and Kettenmann, 2007). Microglia are the only 
cells in the CNS parenchyma that are neither neural cells nor vascular cells. The term 
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―microglia‖ was introduced in 1919 by del Rio-Hortega, who suggested that these cells 
could transform into migratory phagocytotic cells (Ransohoff and Cardona, 2010). 
Microglia comprise about 10% of cells in the CNS, with the proportion varying between 
5% and 15% depending on the location in the neuroaxis and the stage of development 
(Perry et al., 1985; Ransohoff and Cardona, 2010). Microglia can also be distinguished 
from the other mononuclear phagocytes, such as meningeal, choroid plexus and 
perivascular macrophages, based on their location and marker profile (Verney et al., 
2010). Microglia survey their environment and can respond to any damage or infection, 
as outlined below. As phagocytes, they can, for example, engulf dead cells and debris. As 
the CNS develops, they also participate in synaptic remodeling by removing improper 
synaptic connections through phagocytosis (Allen and Barres, 2009). 
 
1.3.1 The origin of microglia 
 
The origin of microglia (specifically whether microglial cells are of myeloid lineage or 
neuroectodermal origin) is an unresolved controversy. Today, microglia are widely 
believed to come from at least two sources: One subpopulation originates in the 
mesoderm from myeloid precursors produced in the yolk sack during embryogenesis, 
while another is derived from myeloid hematopoietic stem cells that enter the brain after 
birth (Alliot F, 1999; Ginhoux et al., 2010; Verney et al., 2010).  
 
1.3.2 Maturation and activation of microglia 
 
In the early stages of development, microglia exhibit amoeboid morphology. These 
amoeboid cells mature into a ramified phenotype, with small cell soma and long thin 
processes (Fig.1.3.2) (Ransohoff and Cardona, 2010). This change is usually 
accompanied by a decrease in antigen expression. At 4.5 to 5.5 gestational weeks (gw), 
amoeboid microglia colonize the human forebrain and cerebral cortex (Verney et al., 
2010). In the adult brain, most microglia exhibit ramified features associated with a 
―resting‖ phenotype. Some researchers have suggested renaming these ―resting 
microglia‖ as ―surveying microglia‖ to reflect their role in homeostatic surveillance and 
detection of pathological changes (Graeber, 2010; Hanisch and Kettenmann, 2007; 
Kreutzberg, 1996; Nimmerjahn et al., 2005). It has been assumed that because microglia 
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perform this surveillance function, abnormal physiology among microglial cells can 
affect homeostasis in the CNS.  The microglial turnover rate under physiological 
conditions, in terms of constitutive proliferation and replenishment, is probably low. 
In CNS diseases, in particular in the case of neurodegenerative disorders, 
significant increases in the number and activation of microglia are often observed.  
Microglia can be activated by various signals and modulators—including infectious 
agents, cytokines or chemokines—that induce different phenotypes (Hanisch and 
Kettenmann, 2007). Activation of microglia results in an amoeboid morphology. This 
involves the enlargement of the soma, the shortening of processes and the up-regulation 
of myeloid cell markers (Ransohoff and Cardona, 2010). ―Activated‖ microglia are also 
known as ―reactive‖ or ―effector‖ microglia because of their adaptive responses to 
challenges. In certain pathologic conditions, additionally large numbers of monocytes 
infiltrate the CNS (Hanisch and Kettenmann, 2007; Mildner et al., 2007). Though 
microglia and macrophages can both be stimulated by the same signals and express some 
of the same markers, their activation patterns and profiles differ (Ransohoff and Perry, 
2009).  
 
 
 
Fig. 1.3.2: Plasticity of microglial morphology and the activation cascade. (A) Ramified or resting or 
surveying microglia (B) intermediate or altered microglia (C) activated or reactive or effector microglia. 
Reactive microglia remove debris through phagocytosis (figure modified from Graeber, 2010; Verney et al., 
2010). 
 
1.3.3 Microglia in CNS malignancies 
 
Microglia are important for cell development, neurogenesis and regeneration, and for 
neurological disorders (Fig.1.3.3) (Hanisch and Kettenmann, 2007; Ransohoff and 
Cardona, 2010; Ransohoff and Perry, 2009).   
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Fig. 1.3.3: Activity states of microglia. (Left) In healthy tissue, ―resting‖ or ―surveying‖ microglia (1) 
monitor the CNS environment. Neurons (2) may deliver signals to keep microglia in this surveillance state. 
Perivascular macrophages (3) are also found close to the blood vessels. (Middle) When limited, localized 
damage occurs, such as minor vascular or tissue damage (4), microglia detect it rapidly and take on the 
alerted profile. Neighboring astrocytes (5) may release signals that contribute to activation. Microglia can 
produce neurotrophic factors (6) to support endangered neurons. Disruption of communication would let 
endangered neurons signal to microglia for assistance (7). Neurons can also emit signals that they seldom 
release (8) to indicate that functions have been disrupted. (Right) If damage to the CNS is more significant, 
microglia can adopt the reactive profile (9) and change their phenotype (figure taken from Hanisch and 
Kettenmann, 2007). 
 
By contrast, their roles in metastasis are almost unknown. The brain is a significant and 
common metastatic site for certain types of cancer. Although the BBB isolates central 
cells from peripheral tissues and tightly regulates entry to the CNS, it does not always 
succeed in blocking metastasis. Yet although patients with brain metastases have a poor 
prognosis, investigations about the role of microglia in brain malignancies tend to focus 
exclusively on primary brain tumors. Previous research has found a correlation between 
the degree of infiltrating macrophages in astrocytic tumors and the grade of the glioma 
(Roggendorf et al., 1996). A variety of substances produced by microglia, such as 
cytokines and growth factors, may help glioma cells to effectively escape from the 
immune system (Markovic et al., 2005; Watters et al., 2005). Moreover, Galarneau and 
colleagues have found that microglia are rarely phagocytic or inducing apoptosis in 
glioma cells (Galarneau et al., 2007). Unfortunately, we know even less about the role of 
microglia in brain metastasis of epithelial cancers, which are more frequent than 
malignant gliomas.  
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1.4 Signaling pathways in tumor progression 
 
1.4.1 Wnt signaling pathways 
 
The term Wnt is a combination of the names for the Drosophila melanogaster segment-
polarity gene Wingless (Wg), first described in 1973, and Integrase-1 (Int1), first 
described in 1982. Wg was first observed in a mutated Drosophila melanogaster that 
lacked wings. The gene later turned out to be the homologue of mammalian Int1, which 
was described by Roel Nusse and Harold Varmus in 1982, who found that a tumor virus 
expressed Int1 can induce mammary gland tumors in mice (Nusse and Varmus, 1982; 
Sharma, 1973). Nüsslein-Volhard and Wieschaus found that several genes including Wg 
mutation produced segmentation defects and segment-polarity gene mutations in 
Drosophila, a discovery that won them the 1995 Nobel prize in Physiology or Medicine 
(Klaus and Birchmeier, 2008; Nusslein-Volhard and Wieschaus, 1980). Since then, 
research has greatly expanded our understanding of Wnt signal transduction (McMahon 
and Bradley, 1990; van Amerongen and Berns, 2006).  
The mammalian genome includes 19 Wnt ligands, 10 Frizzled (Fz also known as 
FZD) receptors and two low-density lipoprotein receptor-related protein (LRP) 
coreceptors. All 19 Wnt genes encode lipid-modified secreted glycoproteins (van 
Amerongen and Berns, 2006). The nomenclature of the Wnt family refers to the amino 
acid sequences rather than their functional properties. Different combinations of Wnt and 
receptor interactions result in a variety of effects. Wnt signaling is also able to crosstalk 
with other signaling pathways, such as bone morphogenic protein (BMP), Notch or 
Hedgehog (Hh) signaling (De Strooper and Annaert, 2001; Guo and Wang, 2009; 
Nakamura et al., 2007). There are also physiological Wnt inhibitors regulating the 
activity of the pathway. For example, secreted and soluble forms of the receptors Fzs, 
called secreted Frizzled-related proteins (sFRPs), could act as antagonists that prevent 
Wnt from binding to membrane-bound Fzs. In the late 1990s, the Wnt inhibitors 
Dickkopf 1 to 3 (DKKs) and Wnt inhibitory factor (WIF1) were also identified (Klaus 
and Birchmeier, 2008). More information on Wnt genes and signaling components can 
be found on The Wnt Homepage hosted by Stanford University 
(http://www.stanford.edu/~rnusse/Wntwindow.html). 
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1.4.1.1 Canonical Wnt signaling 
 
Historically, Wnt signaling pathways have been divided into two classes, namely the 
―canonical‖ and ―noncanonical‖ branches, both of which are activated when extracellular 
Wnt binds to the transmembrane Fz receptors. The noncanonical branch is at least 
subdivided into planar cell polarity (PCP) and Wnt-Ca
2+
 pathways (Klaus and 
Birchmeier, 2008). The canonical Wnt pathway is also known as Wnt-β-catenin signaling, 
which involves β-catenin and members of the T-cell factor (TCF) /lymphocyte-enhancer-
binding factor (LEF) transcription factor family. The stability of β-catenin plays a key 
role in this pathway. In absence of Wnt ligands, cytoplasmic β-catenin is phosphorylated 
by the scaffolding complex, consisting of axis inhibition protein (Axin), adenomatosis 
polyposis coli (APC), casein kinase 1α (CK1α) and the serine/threonine kinase glycogen 
synthase kinase 3β (GSK-3β), which results in proteasomal degradation of β-catenin. 
Binding of Wnts to its receptor Fz and coreceptor LRP5/LRP6 inhibits the degradation of 
β-catenin, which accumulates in the cytoplasm and translocates into the nucleus 
(Fig.1.4.1). There, it binds to the TCF/LEF transcription factors and regulates the Wnt-β-
catenin-target genes, including avian myelocytomatosis virus oncogene cellular homolog 
(c-myc), cyclin D1, Axin2 and others (Klaus and Birchmeier, 2008; Staal et al., 2008; 
van Amerongen and Berns, 2006). 
 
1.4.1.2 Noncanonical Wnt signaling  
 
The Wnt-Ca
2+
 pathway is one of the noncanonical Wnt pathways (Fig. 1.4.1). It can be 
activated by Wnt5a, thus forming a Wnt5a-Fz complex and activating via a G-protein 
phospholipase C (PLC). Afterwards, PLC leads to a release of intracellular Ca
2+
. The 
increase in Ca
2+
 activates Ca
2+
/calmodulin-dependent protein kinase II (CaMKII), protein 
kinase C (PKC) or the nuclear factor of activated T-cells (NFAT). Research has shown 
this pathway to be multifunctional, playing an important role in cell adhesion and cell 
movements (Kikuchi et al., 2011; Kohn and Moon, 2005; Pukrop and Binder, 2008; Staal 
et al., 2008). 
Another noncanonical Wnt pathway is made up by the planar cell polarity (PCP) 
/convergent extension (CE) pathway. PCP/CE signaling is generally activated by Wnt5a 
and Wnt11 via Fz receptors and dishevelled protein (Dvl). Dvl subsequently activates 
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small GTPases, including the Ras homologue gene family A (RHOA) and Ras-related C3 
botulinum toxin substrate 1 (RAC1), which activates the stress kinase c-jun N-terminal 
kinase (JNK) and transcription factor c-jun (Fig. 1.4.1). The PCP/CE pathway is 
important for convergent extension movement, neural tube closure and tissue 
morphogenesis (van Amerongen and Berns, 2006). 
 
 
 
Fig. 1.4.1: Wnt signaling pathway. Three signaling pathways (β-catenin, planar cell polarity 
(PCP)/convergent extension (CE), and Ca2+ pathways) are involved in Wnt pathways. LRP: low-density 
lipoprotein receptor-related protein; Fz: frizzled; Dvl: disheveled; GSK-3β: glycogen synthase kinase 3beta; 
TCF/LEF: T-cell factor/lymphocyte-enhancer-binding factor; JNK: c-Jun N-terminal kinase; Ror2: 
receptor tyrosine kinase-like orphan receptor 2; Rac: Ras-related C3 botulinum toxin substrate; Rho: Rho-
associated kinase; AP1: activator protein 1; PKC: protein kinase C; CaMKII: Ca2+/calmodulin-dependent 
protein kinase II; NFAT: nuclear factor of activated T-cells (figure modified from Kikuchi etal., 2011; 
Pukrop and Binder, 2008) 
 
In addition to the above mentioned noncanonical pathways via the receptor Fz, Wnt5a 
can also bind to the receptor tyrosine kinase-like orphan receptor 2 (Ror2) to 
subsequently activate JNK directly, and in parallel to inhibit canonical Wnt signaling 
(Pukrop and Binder, 2008; Schambony and Wedlich, 2007).  
 
1.4.1.3 Wnt signaling and tumor progression 
 
Wnt signaling is crucial to various basic developmental processes, such as cell fate 
specification, control of dorsal axis and asymmetric cell division, maintaining the 
. 1. .  Wnt signaling pathways. 
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balance between proliferation and differentiation throughout embryogenesis and 
postnatal life. During development, the signaling pathway is tightly regulated, but cells 
escape this control in the case of tumorigenesis and other diseases.  
 
(A) The role of canonical Wnt in cancer  
Wnt pathways were first linked to human cancer in 1993 (Laconi et al., 2008; Su et al., 
1993). Canonical Wnt signaling controls the stability of β-catenin, and APC is essential 
for its interaction with β-catenin. More than 300 different disease-related APC mutations 
have been reported. More than 85% of patients with familial adenomatous polyposis 
(FAP) or sporadic colorectal cancers (CRCs) exhibit APC mutations. Among these 
mutations, APC deletion is the most common. APC mutations usually lead to truncated 
proteins and further affect binding of β-catenin, Axin1 or Axin2. Mutations of β-catenin 
or APC, or even other Wnt components such as Axin1, 2 are also observed in many 
cancers. About 10% of CRC patients have β-catenin mutations that affect the serine and 
threonine residues targeted by GSK-3α/β or CK1α (Verkaar and Zaman, 2011). In 
addition to CRC patients, a variety of cancers exhibit APC or β-catenin mutations: 20% 
of gastric carcinomas and 75% of pilomatricomas are accompanied by β-catenin 
mutations, while about 20% to 40% of hepatocellular carcinomas (HCCs) and 5% of 
melanomas exhibit β-catenin and APC mutations. Researchers have also observed 
mutations in other components of canonical Wnt signaling, such as Axin1 and Axin2 in 
ovarian carcinoma or HCCs (Giles et al., 2003). Furthermore, mice that ectopically 
express Wnt1 develop mammary and salivary adenocarcinomas, while the Wnt2 gene is 
amplified in mammary tumors. Another study found that mice lacking TCF1 develop 
adenomas in the intestine and mammary glands (Verkaar and Zaman, 2011).  
 
(B) The role of noncanonical Wnts in cancer 
In contrast to several transforming Wnts that are up-regulated or mutated in many 
cancers, little is known about the role of noncanonical Wnts. Wnt5a is the most 
intensively investigated of the noncanonical Wnts, but its role is still controversial. 
Conflicting data indicate that it can either suppress tumors or facilitate them (McDonald 
and Silver, 2009). A high proportion of Wnt5a and Wnt7b has also been observed in 
human breast carcinomas (Giles et al., 2003). Noncanonical Wnts mainly regulate the 
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cytoskeleton, cell migration and polarity. Wodarz et al. have shown that wingless 
signaling modulates cadherin-mediated cell adhesion in Drosophila, which might be a 
critical step in cancer development (Wodarz and Nathke, 2007). Although some studies 
have shown that Wnt5a suppresses tumors by antagonizing the β-catenin pathway, more 
evidence indicates that Wnt5a facilitates tumor progression. Wnt5a correlates with 
aggressiveness in several cancers (Kikuchi and Yamamoto, 2008). 
Studies have identified up-regulation of Wnt5a in a variety of cancers, including 
melanoma, lung cancers, prostate cancers, pancreatic cancers, nasopharyngeal cancers, 
breast cancers and leukemia, and found that this up-regulation increases motility in 
melanoma and gastric cancers (Iozzo et al., 1995; Pukrop and Binder, 2008; Pukrop et 
al., 2006; Sugimura and Li, 2010). Wnt5a-positive patients with prostate cancer showed a 
high ratio of relapse, while both Wnt5a and Wnt5b are highly expressed in cerebral 
metastases of breast cancer patients (Klemm et al., 2011). The prometastatic role of 
Wnt5a may function by activating Rac and JNK pathways. In addition, Nagayama et al. 
found that Fz10 plays a critical role in the metastasis of synovial sarcoma (Nagayama et 
al., 2005). While canonical Wnt signaling plays a role in initiating tumorigenesis, 
noncanonical Wnt pathways seem to facilitate tumor progression (Kikuchi et al., 2011).  
 
(C) Wnt in macrophages and TAMs  
Previous research has shown that the microenvironment of a tumor regulates malignancy, 
while TAMs assist tumor progression. Most research has focused on the direct effects of 
Wnt in tumor cells. However, Wnt signaling in macrophages may also play a role in 
diseases, and this deserves more attention. Although the link between Wnt signaling and 
the immune system has started to draw interest, this relationship remains largely 
uninvestigated (Blumenthal et al., 2006; Ghosh et al., 2009). Wnt signaling in 
macrophages is elevated in many diseases. For example, Wnt5a has been detected in 
patients with severe sepsis (Pereira et al., 2008). It was shown that Wnt5a from tumor 
stromal cells can induce differentiation of basal cell carcinomas via Wnt/Ca
2+
-dependent 
pathway (Nitzki et al., 2010). 
Our research team has previously found that coculture breast cancer cell lines 
with macrophages can induce tumor cell invasiveness, which also led to up-regulation of 
Wnt5a in macrophages. Wnt5a is necessary for MMP-7 and TNFα production by 
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macrophages. This indicates that Wnt5a-mediated noncanonical Wnt signaling increases 
invasiveness by interacting with macrophages, and that the Wnt inhibitor DKK1 can 
antagonize this increase (Pukrop et al., 2006). Ojalvo et al. also found an increase of 
most Wnt ligands in invasive TAMs compared to general TAMs, with Wnt5b and Wnt7b 
showing the highest up-regulation (Ojalvo et al., 2010). Furthermore, when Wnt7b is 
somatically deleted in macrophages, this is accompanied by diminished injury repair 
ability, which indicates that Wnt7b is critical for repair and regeneration (Lin et al., 
2010b). Oguma and colleagues have found that an accumulation of β-catenin in 
macrophage-infiltrated dysplastic mucosa and a depletion in APC mice resulted in the 
suppression of intestinal tumorigenesis, which suggests that macrophages contribute to 
tumor development in the gastric mucosa by promoting Wnt/β-catenin signaling (Oguma 
et al., 2008).  
  
1.4.2 Toll-like receptors (TLRs) signaling pathways 
 
1.4.2.1 Components and activations of TLR signaling 
 
The mammalian Toll-like receptors (TLRs) are the homologues to the Drosophila gene 
Toll that was first described by Christiane Nüsslein-Volhard in 1985. Toll is essential for 
establishing dorsoventral polarity during embryogenesis and producing antimicrobial 
proteins in Drosophila melanogaster (Hashimoto et al., 1988; Lemaitre et al., 1996; 
Trinchieri and Sher, 2007). At least 13 TLRs have been identified in mammals so far. 
They are expressed by a variety of cells, including macrophages, dendritic cells, B or  T 
cells and even non-immune cells, such as fibroblasts and epithelial cells (Akira et al., 
2006). Some TLRs (such as TLR1, 2, 4, 5 and 6) are found on the cell surface, where 
they recognize membrane components of microorganisms. Others (such as TLR3, 7, 8 
and 9) are exclusively found in the cytosol, where they recognize nucleic acid-like 
structures (Kawai and Akira, 2009). The TLRs belong to the Toll/interleukin-1 (IL-1) 
receptor (TIR) superfamily, which comprises two main groups and triggers similar signal 
transduction cascades: the IL-1 receptors and the TLRs. TLRs are pattern-recognition 
receptors (PRRs) that can recognize a broad spectrum of pathogen-associated molecular 
patterns (PAMPs), such as peptides, nuclear acids, lipids and carbohydrate structures 
from viruses, bacteria, fungi and parasites (Akira and Takeda, 2004). In addition, 
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intrinsic molecules, including high-mobility group box 1 (HMGB1), heat-shock protein, 
fibrinogen, fibronectin, heparin, fatty acids, amyloid-β and modified LRPs can also 
activate TLR signaling. This suggests that TLRs might serve as sensors designed to 
detect extrinsic PAMPs and intrinsic damage-associated molecular pattern molecules 
(DAMPs) (Hanish et al., 2008; Kawai and Akira, 2010; Miyake, 2007).  
TLRs have a conserved cytoplasmic TIR domain (Kawai and Akira, 2009). After 
homo- or hetero-dimerization of the TLRs, the TIR domain is necessary to recruit TIR-
domain-containing adaptors to transfer the signal. These adaptors are the myeloid 
differentiation primary response gene 88 (MyD88), TIR-domain-containing adaptor 
protein (TIRAP also known as MyD88-adaptor-like protein, MAL), TIR-domain-
containing adaptor-inducing IFNβ (TRIF, also known as TICAM1) and TRIF-related 
adaptor molecule (TRAM, also known as TICAM2). TRAM and TIRAP serve as sorting 
adaptors to recruit MyD88, TRIF or both to the various TLRs. Most of the TLRs use 
MyD88 to drive inflammatory responses via nuclear factor-B (NF-B) and mitogen-
activated protein kinase (MAPK), except TLR3. TLR3 uses the TRIF adaptor alone and 
activates IFN regulatory factor 3 (IRF3), subsequently triggering production of type I 
IFNs. Therefore, TLRs could be classified as either MyD88- or TRIF-dependent (Kawai 
and Akira, 2010; Trinchieri and Sher, 2007). TLR4 has an exceptional position in the 
TLR family. TLR4 uses all adaptors TRAM, TIRAP, TRIF and MyD88 for signaling. 
TLR4 recruits a TIRAP-MyD88 complex to drive the fast inflammatory responses and 
uses TRAM-TRIF to induce type I IFNs as well as delayed inflammatory cytokines. 
TRAM molecules form a complex with TRIF only in TLR4 and not in TLR3 signaling. 
Notably, activation of the MyD88-TIRAP pathway precedes the TRIF-TRAM pathway 
in TLR4 responses (Kawai and Akira, 2009). It is not known why TLR4 signaling uses 
such a comprehensive system to induce inflammation. 
  
1.4.2.2 TLR signaling and tumor progression 
 
In the 19
th
 century, Rudolf Virchow was the first to observe that chronic inflammation 
and inflammatory filtrates accompanied malignant cancers (Balkwill and Mantovani, 
2001; Kim and Karin, 2011). As mentioned above, there can be no doubt that TLR 
signaling plays an important role in both innate and adaptive immune responses. At the 
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same time, increasing evidence indicates that TLR signaling plays a crucial role in 
cancers. Intrinsic or extrinsic TLR activators may be responsible for inflammation in the 
tumor microenvironment (Kim and Karin, 2011). Park et al. have previously found a 
correlation between TLR signaling and tumor progression and metastasis via the intrinsic 
mediator—HMGB1 (Park et al., 2004). 
 
 
 
Fig. 1.4.2: Toll-like receptor (TLR) signaling. TLR1, 2, 4, 5 and 6 are found on the cell surface, while 
TLR3, 7, 8 and 9 are found in internal cell compartments. TLR2 usually forms heterodimers with TLR1 or 
TLR6, while TLR4 forms homodimer complexes with MD2 with assistance from CD14. Extrinsic or 
intrinsic signals from microorganisms can active TLR signaling via either MyD88 or TRIF-dependent 
pathway. TLR4 is the only TLR that uses both of these pathways. All TLRs except TLR3 use the MyD88 
adaptor, leading TAK1 activation, which eventually activates MAPK and NF-B and drives the release of 
inflammatory cytokines. TRIF activates IRF3, which drives the release of type I IFNs and inflammatory 
cytokines. More recently, MyD88 has been found to enhance the release of type I IFNs via IRF7 pathway 
during the activation of TLR7 and TLR9. TLR: Toll-like receptor; MyD88: myeloid differentiation 
primary response gene (88); TRIF: TIR-domain-containing adaptor-inducing IFNβ; TIRAP: TIR-domain-
containing adaptor protein, a bridging adaptor for MyD88 recruitment; TRAM: TRIF-related adaptor 
molecule, a bridging adaptor for TRIF recruitment to TLR4; MAPK: mitogen-activated protein kinase; 
NF-B: nuclear factor-B; IRF: IFN regulatory factor, TAK1: transforming growth factor-β-activated 
kinase 1 (a MAPK kinase kinase); JNK: c-jun N-terminal kinase (figure modified from (Liew et al., 2005; 
Trinchieri and Sher, 2007). 
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TLR2-deficient mice have exhibited significantly greater survival rates than wildtype 
mice upon inoculation with Lewis lung carcinoma, while another paper demonstrated 
that MyD88-deficient mice also had higher survival rates and less polyps (Kim et al., 
2009; Rakoff-Nahoum and Medzhitov, 2007). At the same time, other evidence indicates 
that TLR agonists can serve as an adjuvant in tumor reduction (Adams, 2009). Indeed, 
the role that TLRs play in tumor progression differs among different cancer types, and 
evidence can be found both of tumor-supporting and tumor-inhibiting roles (Wolska et 
al., 2009).  
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2. Aim of the Study 
 
In terms of tumor progression, the role of the microenvironment is as important as the 
characteristics of the tumor cells themselves. It is surprising then that the 
microenvironment has drawn such little interest. It is well documented that TAMs assist 
tumor progression. Interestingly, all the major target organs of metastasis possess tissue-
specific macrophage populations, such as Kupffer cells in the liver, alveolar macrophages 
in the lungs and microglia in the CNS. It is tempting to speculate that resident 
macrophages may play an even more important role for colonization than peripheral 
blood-derived TAMs (PBMs), but to date this question has barely been addressed. 
Because of the severe clinical/therapeutical problems involved, we focused on evaluating 
the role of microglia in the process of cerebral metastasis. To clarify whether microglia 
play a role in solid-cancer metastasis, we investigated the influence of microglia on the 
ability of breast cancer cells to invade and colonize brain slices. To date, there is no 
established marker to distinguish resident microglia from invading monocytes. For our 
purposes, we established a new model, in which PBMs are absent. 
Furthermore, Wnt and TLR signaling are both known to play roles in the 
development and progression of tumors. We were interested in the role of Wnt and TLR 
signaling in microglia-induced tumor progression. This thesis is one part of a project 
funded by the German Research Foundation (DFG) investigating the role of Wnt 
signaling in development and tumor progression. The aims of this thesis are as follows: 
 
(1) To optimize a new coculture model that allows us to investigate the colonization of a 
brain slice by tumor cells and to visualize interactions between stromal cells and 
tumor cells 
(2) To investigate whether microglia play the same role as TAMs in tumor progression 
(3) To determine the role of Wnt signaling in microglia-induced tumor invasion 
(4) To determine the role of TLR signaling in microglia-induced tumor invasion 
(5) To determine whether there is a link between Wnt and TLR signaling in terms of 
tumor regulation 
(6) To identify common targets of Wnt and TLR signaling. 
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3. Materials and Methods 
 
3.1 Chemicals and recombinant proteins 
 
Table 1: List of chemicals and recombinant proteins 
 
Abbreviation Name Supplier 
AMD3100 
(CXCR4 antagonist) 
AMD 3100 octahydrochloride Sigma 
8-Br-cGMP    
(permeable cGMP 
analog) 
8-bromoguanosine-3', 5'-cyclic monophosphate Sigma 
Clodronate clodronate disodium Roche 
IFNβ mouse interferon β 
Pbi interferon 
source 
IL-10 moue interleukin-10 R&D 
JNK inhibitor control 
peptide 
N1-methyl-1, 9-pyrazoloanthrone Calbiochem 
JNK inhibitor 
anthra[1, 9-cd]pyrazol-6(2H)-one; SAPK Inhibitor II; 
SP600125; 1, 9-pyrazoloanthrone 
Calbiochem 
MALP-2 
(TLR2/6 agonist) 
macrophage-activating lipopeptide-2 ALEXIS 
MTT 
2-(4, 5 dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium 
bromide (MTT) 
Sigma 
L-NAME 
(NO synthase inhibitor) 
Nω-nitro-L-arginine methyl ester 
Cayman 
Chemical 
LPS lipopolysaccharide from E. coli, serotype R515 (Re) ALEXIS 
Pam3CSK4 
(TLR1/2 agonist) 
Pam3Cys-Ser-(Lys)4. trihydrochloride ALEXIS 
poly (A:U) 
(TLR3 agonist) 
polyadenylic acid-polyuridylic acid sodium salt Sigma 
rDKK1 recombinant Dickkopf related protein 1 R&D 
rDKK2 recombinant Dickkopf related protein 2 R&D 
rWnt5a recombinant Wnt5a R&D 
rWnt3a recombinant Wnt3a R&D 
SB-216763 
(GSK-3 inhibitor) 
3-(2, 4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-
pyrrole-2, 5-dione (glycogen synthase kinase-3 inhibitor) 
Sigma 
sFRPs secreted Frizzled related proteins  R&D 
SNAP (NO donor) S-nitroso-N-acetyl-D, L-penicillamine Alexis 
 
Recombinant proteins and chemicals were purchased from commercial sources as shown 
in Table 1. All working solutions were freshly prepared from frozen or refrigerated 
stocks by dilution in phosphate buffered saline (PBS) or dimethyl sulfoxide (DMSO) 
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immediately prior to use. In experiments involving antagonized antibodies, cells or slices 
were incubated with the respective antibody concentration for 48 h. 
 
 3.2 Animals 
 
All animals were bred and obtained from the animal facility of the University Medicine 
Göttingen, Germany. NMRI and C57Bl/6J wildtype strains were kept under standard 
conditions, and knockout strains—such as for TLR4 (homozygous knockout, TLR4-/-), 
MyD88 (heterozygous knockout, MyD88
+/-
, and homozygous knockout MyD88
-/-
), TRIF 
(heterozygous knockout, TRIF
+/-
, and homozygous knockout, TRIF
-/-
) and Wnt5a 
(heterozygous knockout, Wnt5a
+/-
)—were maintained under specific pathogen-free (SPF) 
conditions. The MyD88
-/-
 strain was obtained from Dr. Shizuo Akira, Osaka, Japan 
(Adachi et al., 1998). The TLR4
-/-
 (Poltorak et al., 1998) and Wnt5a
+/- 
(Yamaguchi et al., 
1999) mice were originally obtained from the Jackson laboratory, Maine, USA. The 
TRIF
-/- 
mice were obtained from Dr. Bruce Beutler, La Jolla, USA (Hoebe et al., 2003). 
Our TRIF, TLR4 and MyD88-deficient mice were kindly provided by Prof. Dr. Uwe-
Karsten Hanisch and Wnt5a mice were kindly provided by Prof. Dr. Heidi Hahn, 
Göttingen, Germany. Animals were treated carefully according to the guidelines for 
animal care at the University Medicine Göttingen. 
 
3.3 Primary cell cultures  
 
3.3.1 Primary microglial cells 
 
Fig. 3.3.1: Morphology of primary murine microglial cells. 
Primary microglial cells were isolated from P0 mice and had a 
high morphological plasticity. Surveying microglial cells 
exhibited a spindle-like morphology.  
 
Primary murine microglial cells were kindly provided 
by Prof. Dr. Uwe-Karsten Hanisch, Göttingen, 
Germany, according to the previously published 
protocol (Hanisch et al., 2004; Regen et al., 2010). After dissection and careful removal 
of the meninges and blood vessels from whole brains of newborn mice (postnatal day 0, 
 i  i  i li l ll .  
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P0), both hemispheres were dissociated mechanically in 2.5% trypsin-EDTA solution 
(Biochrom, Berlin, Germany) at 37ºC for 10 min. DNAse (0.4 mg/ml, CellSystem, St. 
Katherine, Switzerland) was added to stop the enzymatic reaction for another 5 min, 
followed by centrifugation at 4ºC for 10 min. Cells were resuspended and further 
cultivated in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, Karlsruhe, 
Germany), supplemented with 10% fetal calf serum (FCS, Invitrogen/Gibco, Karlsruhe, 
Germany), 100 U/ml penicillin and 100 µg/ml streptomycin (Biochrom, Berlin, Germany) 
in T75 flasks coated with poly-L-lysine (200 μg/ml, Sigma, Munich, Germany) in a 
humidified atmosphere with 5% CO2 at 37ºC incubator as used previously (Hanisch et al., 
2004; Regen et al., 2010). The culture medium was changed every other day. After 10 to 
14 days, microglia were harvested by shaking them off the astrocytic monolayer 
according to the different adhesion properties of microglia and astrocytes. The purity of 
microglia was more than 98% by using immunohistochemistry staining for the microglial 
marker cluster of differentiation molecule 11b (CD11b), ionized calcium binding adaptor 
molecule 1 (Iba1) and Griffonia simplicifolia isolectin B4 (ILB4).  
 
3.3.2 Primary astrocytic cells 
 
Fig. 3.3.2: Morphology of primary astrocytic cells. Primary 
astrocytic cells were isolated from P0 mice and exhibited a 
stellate morphology.  
 
Primary murine astrocytes were prepared like 
microglial cells, as to the first steps. Upon reaching 
confluence, cells were passed three times to remove 
microglia, after which clodronate (200 µg/ml, Roche, 
Basel, Switzerland) was applied for 48 h to deplete remaining microglia. Astrocytic cells 
were cultivated in DMEM medium supplemented with 10% FCS, 100 U/ml penicillin 
and 100 µg/ml streptomycin at 37 °C and 5% CO2.  
 
3.4 Cell lines and transfection 
 
The human breast cancer cell line MCF-7 was purchased from DSMZ (ID: ACC 115, 
German Collection of Microorganisms and Cell cultures, Braunschweig, Germany) and 
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the Madin-Darby canine kidney cell line (MDCK) is from ATCC (Wesel, Germany). 
Cells were maintained in Roswell Park Memorial Institute medium (RPMI) -1640 
medium (PAA Laboratories Inc., Cölbe, Germany) supplemented with 10% fetal bovine 
serum. Regular controls for mycoplasma infection were negative. 
 
3.4.1 MCF-7 cells 
 
Fig. 3.4.1: Morphology of MCF-7 cells. 
 
MCF-7 (Michigan Cancer Foundation-7) cells are 
human breast adenocarcinoma cells that were isolated 
from the pleural effusion of a Caucasian woman with 
metastatic mammary carcinoma (after radio- and 
hormone therapy). Cells were described with 
epithelial-like characteristics growing as monolayer and with positivity for the 
cytoplasmic estrogen receptor (ER) (Soule et al., 1973).   
 
3.4.2 MDCK cells 
 
Fig. 3.4.2: Morphology of MDCK cells. 
    
The MDCK (Madin Darby Canine Kidney) cell line 
was derived from the kidney of an apparently normal 
adult female cocker spaniel in September 1958 by S.H. 
Madin and N.B. Darby. The cells grow as monolayer 
with epithelial morphology (Gaush et al., 1966). 
 
3.4.3 Cell transfection 
 
Cells were stably transfected with nanofectin (PAA Laboratories Inc., Cölbe, Germany), 
following the manufacturer’s protocol using a mammalian expression vector encoding 
green fluorescence protein (Turbo GFP, FP512, Evrogen Inc., Heidelberg, Germany). 
Cells were maintained in RPMI-1640 medium (PAA Laboratories Inc., Cölbe, Germany) 
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supplemented with 10% fetal bovine serum. To obtain a homogenous cell population, we 
used a FACS Vantage cell sorter (BD FACS Aria II, Heidelberg, Germany). 
 
  
 
Fig. 3.4.3: Morphology of GFP-transfected cells. (A) MCF-7-turbo GFP cells; and (B) MDCK-turbo 
GFP cells. 
 
3.5 ECM-based migration assay 
 
Cancer cells were grown on cover slips, and cells at 90% confluency were transferred 
upside-down to an ECM-coated six-well plate. Measurement was started at 0 h, when a 
clearly visible front of outgrowing cells was observed. This protocol was published 
previously (Pukrop et al., 2010). We stimulated cells with or without clodronate every 
other day. Migration was analyzed by time-lapse microscopy with phase contrast (DMI 
6000B, Leica, Wetzlar, Germany) and distances were quantified after 96 h using the 
Axio-vert 200M microscope and the program Axiovision Rel. 4.6.3 (Zeiss, Göttingen, 
Germany).  
 
3.6 Microinvasion assay (modified Boyden chamber assay) 
 
Fig. 3.6: Scheme of the microinvasion assay. The 
chamber contains microglial cells (MG) placed on top of 
an insert with 0.4 µm pore size without cell-to-cell 
contact with tumor cells placed on a 10 µm 
polycarbonate membrane.  
     
The microinvasion assay was performed with a 
modified Boyden chamber system, that has 
been previously described in detail (Hagemann 
.  
 
 the microi i s
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et al., 2004). The membrane consists of polycarbonate (10 µm pore diameter, 
Nucleopore® , Pleasanton, CA) and was coated with matrigel (ECM gel, 1:3 dilution in 
serum-free RPMI medium) on ice. We measured cancer cell invasion by counting the 
cancer cells in the lower chamber that invaded through the artificial basement membrane. 
Cocultures with microglial cells were performed with cell culture inserts (BD, 
Heidelberg, Germany) in the upper chamber, without cell-to-cell contact to the cancer 
cells (Fig. 3.6). 10
5 
of MCF-7 or MDCK cells were seeded into the upper chamber, while 
the lower chamber was filled with RPMI medium. The experiments were done with 10% 
FCS. To investigate whether a microglia coculture would affect the invasion capacity of 
MCF-7 or MDCK cells, microglia (2 x 10
5
 cells/ml) were seeded in a transwell insert in 
the upper chamber and cocultured for up to 96 h. Afterwards, the content of the lower 
chamber with floating as well as adherent cells was removed and pelleted by 
centrifugation. The cell pellet was resolved in 200 µl of PBS and cell numbers were 
counted under a microscope (per 10x magnification field). 
 
3.7 Organotypic brain slice coculture system  
 
This new model is an adaption with additions of a previously published organotypic 
hippocampal brain slice approach (De Simoni and Yu, 2006; Fuller and Dailey, 2007; 
Kreutz et al., 2007; Stoppini et al., 1991). The summarized protocol is illustrated in Fig. 
3.7.1 and 3.7.2.  
 
3.7.1 Organotypic brain slices 
 
The organotypic brain slice model described by Gähweiler preserves the cytoarchitecture 
of the original tissue. Gähweiler et al. described and compared three techniques used for 
the preparation of organotypic cultures (Gahwiler et al., 1997). The interface organotypic 
slice culture technique first described by Stoppini involves a culture at the interface 
between the air and culture medium (Stoppini et al., 1991). The organotypic organization 
can be preserved effectively for days to weeks in this culture, making it suitable for 
studies of the physiological mechanism. Cultures grown by the interface method are 
ideally suited for experiments that require a three dimensional structure.  
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Fig. 3.7.1: Preparation of the organotypic brain slice culture. (A-D) Devices and materials for the 
preparation (see text). (E, F) P6-8 mice were decapitated. (G-I) Skulls were removed and transferred to a 
dissection medium dish. (J-K) 5% agarose was used to stabilize the brain, followed by vibratome slicing 
with 350 μm thickness. (L) 4 to 5 slices could be obtained from each mouse brain. 
 
The organotypic brain slice coculture can be subdivided into two steps. Step one is the 
preparation of the organotypic brain slice (Fig. 3.7.1). Mice of the C57BL/6, NMRI or 
knockout strains were decapitated between postnatal day six and eight (P6-8). The brain 
was rapidly removed from the skull under sterile conditions and transferred to ice-cold 
dissection medium (Fig.3.7.1E-I). The dissection medium consists of minimum essential 
medium (MEM, Gibco, Germany), supplemented with 0.2 mM glutamine, 100 U/ml 
penicillin, 100 mg/ml streptomycin, and 4.5 mg/ml glucose. After removal of the frontal 
pole and the cerebellum, horizontal brain sections of 350 μm thickness were prepared by 
using a vibratome (Leica VT1200S; Leica Co., Heidelberg, Germany, Fig. 3.7.1J-K). 
2 .  
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Four to five whole brain slices can be collected from a single mouse brain, depending on 
the species and age (Fig. 3.7.1L). Two hippocampal slices can be obtained from a whole 
brain slice by cutting the tissue along the midline, using a scalpel under an anatomy 
microscope (Stemi SV11, Zeiss, Jena, Germany). 
 
3.7.2 The slice coculture model 
 
Several techniques have been used to coculture organotypic hippocampal slices with 
other cells. These include an indirect system between macrophage cells and the 
organotypic brain slice (Brana et al., 1999), and a direct coculture of two different slices 
from the hippocampal region (Kim et al., 2003). Glioma aggregates have also been 
cocultured with brain slices (Matsumura et al., 2000). These models analyze cellular and 
molecular events in the brain slices but do not allow direct, physiological contact 
between tumor cells, microglia and the brain parenchyma. For the reason above, I further 
optimized a new coculture system. 
As an addition to the above described method, cocultures were prepared with 
(tumor) cells which got embedded in matrigel and then placed just adjacent to the 
organotypic brain slice (step two, Fig. 3.7.2). First, the hippocampal or whole brain slices 
were positioned on a 0.4 µm polycarbonate membrane of a transwell membrane insert 
(Falcon model 3090, Becton Dickinson, Heidelberg, Germany) and cultured for 16 h in 
cultivation medium containing 50% MEM, 25% Hanks’ balanced salt solution (HBSS, 
Gibco, Karlsruhe, Germany ), 25% normal horse serum (NHS), 0.2 mM glutamine, 100 
U/ml penicillin, 100 mg/ml streptomycin (Sigma, Munich, Germany), and 4.5 mg/ml 
glucose (Fig. 3.7.2A and B). 10
5
 of MCF-7 or MDCK cells were prepared by embedding 
in 20 μl gel matrix, consisting of 15% RPMI medium and 85% ECM gel (Sigma, 
Deisenhofen, Germany). One cell plug was then placed into a sterile metallic spacer (3.8 
mm diameter), directly adjacent to the cortical region of the organotypic brain slice (Fig. 
3.7.2 C, D1-2). After 2 h, the spacer was removed to allow the cell plug to be in and 
coculture with the organotypic slice for 24 to 96 h (Fig. 3.7.2E1 and E2). Cocultures 
were then followed, monitored and analyzed by time-lapse video microscopy, 
immunoflourescence staining, confocal microscopy as well as conventional 
immunohistochemical methods. 
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Fig. 3.7.2: Illustration of a tumor cell coculture adjacent to the organotypic brain slices. (A) The 
essential materials for this protocol comprised cultivation medium, extracellular matrix (ECM) gel, spacer 
and a 0.4 µm polycarbonate membrane of a transwell membrane insert. (B) Slices were placed on the insert 
for 16 h, followed by (C-D) cell seeding into a 3.8 mm diameter spacer (S) adjacent to the cortical region 
of the brain slice for 2 h (CTX, cortex; OLF, olfactory bulb; HIP, hippocampus; CA, Cornu 
Ammonis areas). (E) Overviews of the complete coculture system (T, tumor cell plug, BS, brain slice).  
 
3.7.3 Rescue experiments 
 
To further understand the mechanism of tumor reducing effects and the role of microglia 
in knockout mice, rescue experiments were performed with the slice coculture method 
(see 3.7.2). MCF-7 cells (10
5
) were placed in the ECM plug with or without 2 x 10
5
 
primary microglia cells from wildtype strain, cocultured as described in Materials and 
Methods 3.7.2 and followed by fixation with 4% paraformaldehyde (PFA) after 96 h 
coculture. For these mixed systems and their corresponding controls, grades of tumor or 
other cell invasion were determined as described in 3.14. 
 
3
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3.8 Assessment of cell viability 
 
Cell viability was assessed by a 2-(4, 5 dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium 
bromide (MTT)-based colorimetric assay as described previously (Mosmann, 1983). We 
tested the viability of the organotypic brain slices over a time course (0, 16, 48, 96 or 120 
h). One sample served as a positive control after methanol (100%) treatment for 30 min. 
At the selected time points, 1 ml of MTT at a concentration of 0.5 μg/ml was added to 
each well, and tissues were incubated for an additional 4 h. The supernatant was 
aspirated, and 1 ml of lysis buffer (33% DMSO, 64% isopropanol and 3% formic acid) 
was added to dissolve any precipitate present for 10 min. The absorbance was then 
measured at a wavelength of 595 nm using a microplate reader (Model 680, Bio-Rad 
Laboratories, Munich, Germany). The slices were viable and results were shown in 
Results 4.1.1. 
 
3.9 Quantification of apoptotic cells in the organotypic brain slices 
 
Mouse brain slice cocultures were embedded in paraffin, cut into 2 to 5 µm sections with 
a microtome and mounted on glass slides. Hematoxylin and eosin (HE) staining was 
performed according to standard protocols (Lillie et al., 1976). The extent of apoptotic 
cells that were identified by their typical morphology was quantified by calculating the 
apoptotic percentage (number of apoptotic nuclei in relation to all counted nuclei per 
100x magnification field) under the microscope (BX 41, Olympus, Hamburg, Germany).  
 
3.10 Immunohistochemistry of organotypic brain slices and breast 
cancer brain metastases 
 
For immunoblot and immunohistochemical staining, a panel of primary antibodies was 
employed as listed in Table 2. Human tumor tissues were obtained from neurosurgically 
resected brain metastases with approval of the local ethics committee. Mouse brain slice 
cocultures were embedded and cut into 2 to 5 µm sections as mentioned above (see the 
section 3.9). Immunohistochemistry was performed based on a modified protocol that 
has been described earlier (Nessler et al., 2006). Brain slice coculture sections were de-
waxed, rehydrated and pretreated with 10 mM citrate buffer (pH 6.0) in a microwave 
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oven for 3 to 5 min. Immunostaining was performed with primary antibodies against 
macrophages/activated microglia (Iba1 for mouse and Kim1p for human samples, Iba1, 
1:1000, Wako, Nuess, Germany; Kim1p, 1:500, provided by H.J. Radzun, Göttingen, 
Germany), against tumor cells (pan-cytokeratin, mouse anti-AE1/AE3, M3515, 1:50, 
Dako, Glostrup, Denmark) and against glial fibrillary acidic protein (GFAP) of astrocytes 
(1:200, Dako, Glostrup, Denmark). Bound antibody was visualized using an avidin-biotin 
technique (Boehringer, Mannheim, Germany). Control sections were incubated either in 
absence of primary antibodies, or with isotype controls or with non-immune sera. After 
counterstaining with hematoxylin, slides were coverslipped and analyzed. 
 
Table 2: List of antibodies and fluorescent dyes 
 
Function Antigen Type Dilution Supplier 
Primary 
antibodies 
CXCR4 
polyclonal rabbit anti 
human/mouse 
1:750  
for WB*  
Abcam 
CXCR4-
conjugated PE 
monoclonal rat anti-
mouse  
1:100 
BD 
Pharmingen™ 
GFAP 
polyclonal rabbit anti 
human/mouse 
1:200 Dako 
Iba1  
polyclonal rabbit anti 
human/mouse  
1:1000 Wako 
Kim1p 
polyclonal rabbit anti 
human 
1:500 
provided by 
H.J. Radzun 
pan-cytokeratin 
(AE1/AE3) 
monoclonal mouse anti-
human 
1:50 Dako 
Isotype control PE rat IgG2b 
rat IgG2b, isotype 
control 
1:100 
BD 
Pharmingen™ 
Secondary 
antibody  
IgG-HRP goat anti-rabbit  
1:2000 
for WB* 
Santa Cruz 
Biomolecule 
conjugated with 
fluorescent dye 
Alexa Fluor 568- 
Isolectin IB4 
(ILB4) 
a glycoprotein 
conjugated with red 
fluorescent dye 
1:100 Invitrogen 
Fluorescent dyes 
calcein AM a green fluorescent dye 1:500 AnaSpec 
PI (Propidium 
Iodide) 
a red fluorescent dye 1:1000 AnaSpec 
   *WB, Western blot 
 
3.11 Immunoblot (Western blot) 
 
For Western blot analysis, 10
6
 cells were lysed in 100 µl ice-cold 
radioimmunoprecipitation assay buffer (RIPA buffer, 50 mM
 
Tris-Cl, pH 7.5, 10 mM 
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EDTA, 150 mM NaCl, 0.5% sodium dodecyl sulfate (SDS), 1% Nonidet P-40, 1 mM 
phenylmethanesulfonylfluoride (PMSF), 2 mM NaF, 1 mM Na3VO4) and supplemented
 
with phosphatase inhibitor cocktail (Roche, Basel, Switzerland) and protease inhibitor 
cocktail (Sigma, Munich, Germany). Protein lysates were incubated on ice for 30 min 
and then centrifuged at 14000 rpm for 15 min at 4 °C. Samples of whole cell lysate from 
MCF-7 or primary microglial cells (30 µg each) were processed with 10% SDS-
polyacrylamide gel electrophoresis (PAGE) for separation as previously described 
(Hagemann et al., 2004). The gel contained 8.1 ml distilled water, 5.0 ml of 1.5 M Tris 
and 2% SDS, which is adjusted to pH 8.8, 6.7 ml of 30% acrylamid, 200 µl of 10% 
ammoniumpersulphate (APS) and 20 µl TEMED. A 1X electrophoresis running buffer is 
composed of 25 mM Tris, 192 mM glycine (pH 8.0) and 0.1% SDS. Protein lysates were 
loaded into the wells and the gel was run at 120 voltages (V) for 100 min with 
a minigel system (Biometra, Göttingen, Germany). Then, the protein samples were 
transferred on to the nitrocellulose membrane (Amersham Bioscience, Little Chalfont, 
UK) in a semi-dry blot transfer apparatus (Biometra, Göttingen, Germany) at 10 V for 75 
min.  Membrane was then blocked in tris-buffered saline (TBS, 50mM Tris, 150 mM 
NaCl and 0.05% Tween 20) with 5% bovine serum albumin (BSA, Biomol, Hamburg, 
Germany) for 1 h. CXCR4 antibody and HRP-conjugated secondary antibody were 
purchased from commercial sources and used as shown in Table 2. Signals were 
visualized by enhanced chemiluminescence (ECL) method (GE Healthcare, Pollards 
Wood, UK) with the Fuji LAS 4000 image system. 
   
3.12 Immunofluorescence staining 
 
2 x 10
5 
primary microglial cells were seeded on the coverslip and cultured for 24 h, 
subsequently followed by fixation with 4% PFA. Monoclonal rat anti-mouse CXCR4 
antibody conjugated with PE was used to stain for 1 h in the dark, and PE-conjugated rat 
anti-mouse IgG2b was used as an isotype control. Cell nuclei were counterstained with 
DAPI (1 µg/ml) for 3 min. Subsequently, DAKO fluorescent mounting medium was used 
to mount the cells on the slide. Images were analyzed with a confocal microscope (LSM 
510, Zeiss, Göttingen, Germany). 
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3.13 Time-lapse microscopy of the slice coculture system 
 
Imaging was performed on a Leica inverted DMI 6000B microscope (Leica, Wetzlar, 
Germany) with a 10-fold magnification lens and a Leica DFC 350 FX CCD camera. 
Samples were cultured in a six-well plate with membrane inserts and placed in the moist 
chamber at 37 °C, with 5% CO2 and 95% air and followed by image recording by phase 
contrast as well as fluorescence under a time lapse microscope for up to five days. In 
order to investigate the interaction between microglia and tumor cells, the living slices 
and adjacent tumor cells were stained with 2.5 µg ILB4-Alexa Fluor 568 (1:100 in PBS), 
for 6 to 8 h in advance. Images were processed using the software Video Spin 
(http://www.videospin.com/Redesign/).  
 
3.14 Evaluation of cell invasion, microglia accumulation by confocal 
microscopy and slice levels categorization 
 
Slice cocultures were fixed with 4% PFA. The organotypic whole brain slices and 
adjacent cell plugs were removed together from the cell culture inserts by cutting out the 
underlying membrane, followed by placing them into a 12-well-plate and rinsing with 
PBST (0.2% Triton X-100 in PBS). Non-specific binding was blocked by adding normal 
goat serum (NGS, 1:20 in PBST) at room temperature for 1 h. Microglia were stained 
with ILB4-Alexa Fluor 568 (1:100 in PBST, and 0.5% bovine serum albumin, BSA) at 
room temperature in the dark for 1 h. After washing with PBS, nuclei were 
counterstained with DAPI (4′, 6-diamidino-2-phenylindole, 1:1000, Sigma, Munich, 
Germany). Samples were mounted in DAKO fluorescent mounting medium (Dako, 
Glostrup, Denmark), coverslipped and analyzed with a Zeiss confocal laser scanning 
microscope (LSM 510, Zeiss, Göttingen, Germany). 
The grade of invasion was evaluated using the following scoring system: First, 
the length of the contact section between the tumor plug and slice was measured. 
Invasion was then rated as based on a ranking with +++ ≥ 2/3, ++ = 1/3-2/3 and + < 1/3, 
relating to the fraction of contact section being invaded by MCF-7 or MDCK cells. A 
rank of 0 was given when no or only single invaded cells were detectable. The grade of 
microglial accumulation was categorized similarly and as follows: 4 = ≥ 75%, 3 = 50-
75%, 2 = 25-50%, 1 = < 25% of the area of the whole brain slice surface was positive for 
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microglia. Brain slices were also categorized into three architecture groups, according to 
the anatomical planes they were obtained from. The first and second slices were defined 
as group 1, the third and fourth slices were group 2 and the fifth and sixth slices were 
grouped in category 3. The categories represented different slice architecture and 
ventricle areas (Fig. 3.14, Allen Mouse Brain Atlas, Brain explorer version 1.4.2, Allen 
institute for Brain Science, WA, USA). 
 
 
 
Fig. 3.14: Representative schemes of slices from three categories of slice levels. (Allen Mouse Brain 
Atlas, Brain explorer version 1.4.2).              
 
3.15 Live-dead staining of the tumor cell plug adjacent to the 
organotypic brain slice 
 
MCF-7 and MDCK cells were cocultured with brain slices for up to 96 h. Viable and 
dead cells were quantified using an acetoxymethyl ester of calcein (Calcein AM) and 
propidium iodide (PI) double staining kit (AnaSpec. Inc., California, USA). Calcain-AM, 
which is a cell membrane-permeable compound, stains living cells, while PI stains only 
dead cells. Cell nuclei were counterstained with DAPI (1 µg/ml, 3 min). The calcein 
AM- and PI-positive cells were counted in three random fields with Image J software 
(Image J 1.43f). Results were described as a ratio of the numbers of living cells to total 
cells (live cells/live cells + dead cells). The UV-irradiated samples served as a positive 
control. 
 
3.16 Microarray studies of microglia tumor cell cocultures 
 
Cocultures with microglia were performed with cell culture inserts (0.4 µm pore size, BD, 
Heidelberg, Germany) on the six-well plates without cell-to-cell contact with the MCF-7 
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cells (Fig. 3.6). 10
6 
of MCF-7 cells were seeded into the six-well plates with or without 2 
x 10
6 
primary microglial cells for 24 h. The TRIzol reagent method including DNase I 
digestion (Invitrogen, Karlsruhe, Germany) was used to isolate total RNA (Pukrop et al., 
2010). The amount of RNA was quantified by NanoDrop ND-1000 UV-vis 
spectrophotometer version 3.2.1, and an RNA integrity number greater than 7.5 was 
chosen (using the Agilent 2100 bioanalyzer). 700 ng of total RNA was used for cDNA 
synthesis. Murine 4 x 44K Design (Agilent, Böblingen, Germany), ―low RNA input 
linear amplification kit plus one color‖ (Agilent) and the ―RNA spike-in kit for one 
color‖ (Agilent) protocol were used for a global gene expression analysis as suggested by 
the manufacturer. The labeling efficiency was determined with the Nano-Drop 
Spectrophotometer (>10 pmol/µl). Approximately 1.6 µg of cDNA was fragmented and 
hybridized on the 4 x 44K Agilent microarray for 17 h at 10 rpm and 65ºC in a 
hybridization oven (Agilent). Cy3 intensities were detected by one-color scanning using 
an Agilent DNA microarray scanner at 5-µm resolution. The members of the 
Transkriptomanlyselabor Göttingen (The DNA Microarray Facility Göttingen, Germany) 
performed the microarray experiments (Pukrop et al., 2010).  
 
3.17 Reverse transcription and quantitative real-time polymerase chain 
reaction (qRT-PCR/qPCR)  
 
1 µg of total RNA was used for cDNA synthesis and the final volume of RT reaction was 
always 20 µl. PCR was performed with the ABI-7900 HT real-time PCR detection 
system (Applied Biosystems, Mannheim, Germany) with SYBR green PCR master mix 
(Bio-Rad, Munich, Germany). The following reagents were prepared in a 384-well plate 
on ice: 
 
qPCR reaction 
SYBR Green PCR Master Mix 5 μl 
cDNA (1:4 dilute) 1 μl 
sense primer, 10 μΜ 0.75 μl 
antisense primer, 10 μΜ 0.75 μl 
DEPC water 2.5 μl 
final volume 10 μl 
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All experiments were performed in triplicate and the plate was sealed with adhesive film 
(Applied Biosystems, Mannheim, Germany). After a brief centrifuge spin, qRT-PCR 
reaction was performed using default conditions shown as follows: 
 
 
 
 
 
 
 
 
Primers were designed using PerlPrimer software (v1.1.20) and primer 3 software 
(http://frodo.wi.mit.edu/primer3/). Phosphoglycerate kinase 1 (PGK1) and 18S rRNA 
displayed a high stability, in comparison to other common housekeeping genes, for the 
analyzed mouse brain regions during development, maturation and aging and served as 
reliable control genes (Boda et al., 2009). For this reason, gene expression levels were 
normalized to housekeeping genes (average of PGK and 18S rRNA) and followed by 
analyses with the comparative cycle threshold (Ct) method (Livak and Schmittgen, 2001):  
 
∆Ct = Ct, gene of interest – Ct, housekeeping gene 
∆∆Ct = ∆Ct, sample – ∆Ct, reference 
Fold change = 2
-∆∆Ct
 
 
Table 3: List of primer sequences 
 
PCR program 
initial denaturation   95 °C for 3 min, 1 cycle 
annealing and extension 
95 °C for 15 s; 60 °C for 30 s; 72 °C for 40 s, 40 
cycles 
disassociation/melting curve 15 s each at 95°C, 60°C, and 95 °C 
soak 4 °C 
Gene Name Primer Sequence (5„ to 3„) Product  
Size (bp) 
Reference 
DKK1 Forward: AACTACCAGCCCTACCCT 
Reverse: TGATGCTTTCCTCAATTTCCC 
237  
DKK2 Forward: CATCCTCACCCC ACA TATCC 
Reverse: GTAGGCATGGGTCTCCTTCA 
154  
DKK3  Forward: GTCCTCTGAGGTGAACCTGG 
Reverse: GTCTCGGGTGCATAGCATCT 
300  
Wnt1 Forward: CTCTTCGGCAAGATCGTCA 
Reverse: CGTGGCATTTGCACTCTTGG 
331  
Wnt2 Forward: AGAGTGCCAACACCAGTTCC 
Reverse: TACAGGAGCCACTCACACCA 
425 (Zeng et al., 2007) 
Wnt3  Forward: GGGGCGTATTCAAGTAGCTG 
Reverse: GTAGGGACCTCCCATTGGAT 
106 (Zeng et al., 2007) 
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Wnt3a  Forward: CCCTTTCCAGTCCTGGTGTA 
Reverse: CTTGAAGAAGGGGTGCAGAG 
161 (Verani et al., 2007) 
Wnt4  Forward: AACGGAACTTGAGGTGATG 
Reverse: GGACGTCCACAAAGGACTGT 
345 (Okoye et al., 2008) 
Wnt5a  Forward: CAGTGGACAATACTTCTGTCT 
Reverse: GGATTCGTTCCCTTTCTCTAG 
267  
Wnt5b  Forward :AGTTATGCAGATAGGTAGCC 
Reverse: AAAGTTCTTCTCACGCTCTC 
240  
Wnt6  Forward: ACTGCTGCTGCTGCTCTTGT 
Reverse: CCTGCAGATGCTGGTAGGAT 
95  
Wnt7a  Forward: CGGACGCTCATGAACTTACAC 
Reverse: CCTAGCTCTCGGAACTGTGG 
145  
Wnt7b Forward: TACTACAACCAGGCGGAAGG 
Reverse: CACCTCGCGGAACTTAGGTA 
225  
Wnt8a  Forward: TGTCATGGCATCTCAGGAAG 
Reverse: GCGGTTGCAGTAGTCAGGAG 
240 (Okoye et al., 2008) 
Wnt8b  Forward: GTGGACTTCGAAGCGCTAAC 
Reverse: TTACACGTGCGTTTCATGGT 
316 (Okoye et al., 2008) 
Wnt9a  Forward: CCCCTGACTATCCTCCCTCT 
Reverse: GATGGCGTAGAGGAAAGCAG 
270 (Zeng et al., 2007) 
Wnt9b Forward: AGGAGACGGCCTTCCTGTAT 
Reverse: GCACTTGCAGGTTGTTCTCA 
296 (Okoye et al., 2008) 
Wnt10a  Forward: GCGCTCTGGGTAAACTGAAG 
Reverse: CACACGGTTGTTGTGGAGTC 
302 (Okoye et al., 2008) 
Wnt10b  Forward: GGTGGCTGTAACCACGACAT 
Reverse: CGCTTCAGGTTTTCCGTTAC 
146  
Wnt11  Forward: TGCTTGACCTGGAGAGAGGT 
Reverse: AGCCCGTAGCTGAGGTTGT 
193 (Zeng et al., 2007) 
Wnt16  Forward: CCCTCTTTGGCTATGAGCTG 
Reverse: TACTGGACATCATCCGAGCA 
202 (Zeng et al., 2007) 
VEGFA Forward: GGACCCTGGCTTTACTGCTG 
Reverse: CTATGTGCTGGCTTTGGTGA 
320  
TNFα Forward: TCCCCAAAGGGATGAGAAGT 
Reverse: CTCCTCCACTTGGTGGTTTG 
138  
NOS2  Forward: GTCTTGCAAGCTGATGGTCA 
Reverse: ACCACTCGTACTTGGGATGC 
94 (Tumurkhuu et al., 
2010) 
CXCR4  Forward: GTGCAGCAGGTAGCAGTGAA 
Reverse: TTGCCGACTATGCCAGTCAAG 
248 RvfromPrimerBank 
ID 1542889a2 
CXCL12 Forward: GAGCCAACGTCAAGCATCTG 
Reverse: CGGGTCAATGCACACTTGTC 
100 (Semerad et al., 
2005) 
CSF1R Forward: GCATACAGCATTACAACTGGACC   
                TACC 
Reverse: CAGGACATCAGAGCCATTCACAG 
256 (Weisberg et al., 
2003) 
F4/80 Forward: CGCTGCTGGTTGAATACAGAGA 
Reverse: CGGTTGAGCAGACAGTGAATGA 
325 (Davies et al., 2008) 
PGK1 Forward: GAAGGGAAGGGAAAAGATGC 
Reverse: GCTATGGGCTCGGTGTGC 
136 (Kronsbein et al., 
2008) 
18S rRNA Forward: GTAACCCGTTGAACC CCATT  
Reverse: CCAT CCAATCGGTAG TAGCG 
150  
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3.18 Detection of PCR amplicons by agarose gel electrophoresis 
 
2% agarose gels were prepared in 1X TAE buffer with 0.5 µg/ml ethidium bromide. 10 
μl of PCR products and 2 µl of 100 bp DNA ladder, which serves as a marker (Fermentas 
GmbH, St. Leon-Rot, Germany), were loaded into the wells. Electrophoresis was 
performed at 80 to 100 V for 30 min and DNA was visualized under a UV 
transilluminator (INTAS, Göttingen, Germany) 
TAE buffer (50X): 
 
242 g Tris base 
57.1 ml glacial acetic acid 
100 ml 0.5 M EDTA (pH 8.0) 
ddH2O was added to a final volume of 1 liter 
 
 
3.19 NO measurement 
 
NO synthesis was measured in culture supernatants as the end product,  i.e. nitrite, by 
using Griess reagent (Merck, Darmstadt, Germany) as described (Tumurkhuu et al., 
2010). 10
6 
microglial cells were incubated in six-well plates under a variety of 
stimulation conditions for 24 or 96 h. LPS (100 ng/ml) served as a positive control for 
the effect of L-NAME or Wnt signaling activation on LPS-induced NO release. Four 
hours of pretreatment with SB-216763 (10 µM) was followed by 24 h of stimulation with 
LPS. Then, 100 µl of supernatant was mixed with 100 µl of Griess reagent for 10 min. 
The reaction product was subsequently measured in a microplate reader at the 570 nm 
absorbance (Model 680 microplate reader, Bio-Rad, Munich, Germany). Data were 
normalized to the control group and expressed as percentage.   
 
3.20 Flow cytometry for microglia and MCF-7 
 
Microglial cells were plated at 10
5 
cells/ml with or without stimulation for 24 h. Cells 
were washed once and resuspended in PBS, followed by staining with monoclonal anti-
mouse 2B11/CXCR4 antibody-phycoerythrin (PE) conjugate (1:100 dilution, as shown 
in Table 2). PE-conjugated rat anti-mouse IgG2b was used as an isotype control. A 
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FACS Canto II Flow Cytometer (Becton Dickinson, Heidelberg, Germany) was used to 
collect at least 10,000 events from each sample, and data were analyzed with FlowJo 
software (Tree Star, Ashland, Oregon, USA). Data were normalized and shown as 
percentage of maximum (% of max), i.e. the number of cells in each bin divided by the 
number of cells in the bin that contained the largest number of cells (Backstrom et al., 
2007). 
        75,000 cells/ml MCF-7 were prepared and grown for 24 h followed by applying 
various concentrations of clodronate for another 96 h. Adherent and floating cells were 
labeled with calcein AM (2 µM, AnaSpec. Inc., California, USA) as a marker for living 
cells. FACS analysis was performed on a FACS Calibur flow cytometer (Becton 
Dickinson, Heidelberg, Germany) and data were analyzed using FlowJo software. 
 
3.21 Statistics 
 
All data represent the mean ± standard error of the mean (SEM). Differences were 
analyzed with the Student’s t-test or the Kruskal-Wallis test. To determine statistical 
significance at different time points, we used one-way ANOVA. Correlation between 
tumor invasion and microglial accumulation or the level of brain slices was analyzed 
with a Spearman’s correlation test. P-values less than 0.05 were considered statistically 
significant (
*
p < 0.05; 
**
p < 0.01; 
***
p < 0.001) 
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4. Results 
 
4.1 Part A. Optimization of a new system for studies on tumor-brain 
interactions in tissue slice-tumor cell coculture 
 
Our research team has previously demonstrated that microglia have the capacity to 
enhance cancer cell invasion (Pukrop et al., 2010). To better investigate the direct 
interactions between carcinoma cells and living brain tissue, a new coculture model was 
developed, combining tumor cells and an organotypic mouse hippocampal slice. I further 
used whole brain slices to compare the results with traditional hippocampal slice 
coculture, and optimized this technique by using a variety of methods including variation 
of the amount of tumor cells and ECM volume or applying various methods of tumor-
plug seeding. This technical improvement, leading to both a new design and processing 
of the coculture system, was necessary to standardize especially the positioning of the 
tumor cell plug, in order to achieve reproducible conditions and develop a scoring system 
(see Materials and Methods, 3.14). More than 200 slices were tested for optimization. 
Among the methods tested for seeding the tumor plugs—seeding them directly with a 
pipette, using a glass cover slip as a separator, using plastic straws as a spacer, using a 
homemade spacer and using a metallic spacer—the metallic spacer worked best for 
producing consistent cocultures, in terms of a contact area with the brain slices and the 
density of tumor cells (see Materials and Methods, 3.7.2). Therefore, the metallic spacer 
was applied to the brain slice-tumor cell coculture in subsequent experiments.  
 
4.1.1 Brain slice viability  
 
After optimizing of this novel approach, first the viability of the organotypic brain slices 
was evaluated at different time points. The MTT assay measurements on the organotypic 
brain slices demonstrated that they were still viable after 120 h (Fig. 4.1.1). 
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Fig. 4.1.1: Brain slices viability. The viability was evaluated 
by the MTT assay at different time points. Methanol (MeOH) 
served as a positive control as described in Materials and 
Methods (3.8). Taking brain slices from 0 h as 100%, 
viability was compared for brain slices at 16 h (118 ± 12%), 
48 h (96 ± 21%), 96 h (110 ± 9%) and 120 h (119 ± 18%). 
Methanol reduced the cell viability to 10%. Data represent 
mean ± SEM with n ≥ 9 (*p < 0.05 compared to the 0 h 
group). 
 
4.1.2 Microglia assisted tumor invasion into the brain slices 
 
By microinvasion assays, our group has recently found that microglia can enhance the 
invasion capacity of weakly invasive breast cancer cells. After establishing the coculture 
modifications described above, we were able to quantify invasion of cancer cells into the 
brain slice. To clarify if microglia are also substantially involved in the invasion of 
carcinoma cells into the organotypic brain slices, invasion into slices was analyzed using 
confocal microscopy, with a scoring system ranging from 0 to +++ (described in 
Materials and Methods, 3.14) and by quantifying accumulation of microglia (see 
Materials and Methods, 3.14) in a set of more than 200 tumor cell organotypic brain slice 
cocultures (Fig. 4.1.2). There was a significant correlation between microglia 
accumulation and cancer cell invasion (p < 0.001).  
 
Fig. 4.1.2: Correlation of MCF-7 cell invasion with microglial 
accumulation. Whole brain slices were cocultured with 105 
MCF-7-GFP cells for 96 h and subsequently stained with ILB4-
Alexa Fluor 568. The degree of invasion and accumulation of 
microglia was determined in 203 slice preparations, using 
confocal microscopy (for further details, see the section 3.14). 
Data represent slice numbers and the degree of MCF-7 invasion. 
A Spearman’s test revealed a significant correlation with p < 
0.001.   
 
 
4.1.3 The degree of invasion does not differ in slices of various brain regions 
 
Organotypic hippocampal slices have been widely used for physiological research. In 
order to investigate the effects on different regions of the brain, the grade of tumor 
invasion was determined for cocultures of tumor cells and various brain tissue areas, 
i . . .  rain slice i ili . 
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including the hippocampal formation per se, semi-hemispheres and whole brain slices. 
Results showed no significant difference between these three groups (data not shown). 
For further standardization of the following experiments, the tumor cells were seeded 
adjacent to the cortical region, nearby the hippocampus, of organotypic whole brain 
slices. 
In addition, brain slices were categorized according to three groups as they come 
with differences in brain architecture and ventricle size, as shown in Fig. 3.14 (see 
Materials and Methods, 3.14). No significant differences in tumor invasion were found 
(Fig. 4.1.3).  
 
 
Fig. 4.1.3: Correlation between MCF-7 invasion and the level of 
brain slice. Whole brain slices (frontal sections) were prepared and 
categorized as to their anterior-posterior plane (described in the 
section 3.14), cocultured with 105 MCF-7-GFP cells for 96 h and 
stained for microglia with ILB4-Alexa Fluor 568. The degree of 
invasion was then determined in a total of 168 slices, covering the 
three plane level groups, using confocal microscopy (see Materials 
and Methods, 3.14). Data represent the percentage of the degree of 
MCF-7 invasion into brain slice in each group with n ≥ 49. A 
Spearman’s test revealed no significant difference.   
 
 
4.1.4 Apoptotic cell numbers and IHC results in our new model   
 
Next, the ratio of apoptotic cells was determined in the cortical region exposed to tumor 
cells. To evaluate the suitability of the new coculture setup as to represent a clinical 
model, it was also subjected to experiments with samples of human brain metastases 
from breast cancer patients, using immunohistochemistry staining methods (IHC). 
 
Table 4: Percentage of apoptotic cells in organotypic whole brain slices from a cortical region.  
 
Apoptotic cells % in cortical region (per 100x, n ≥ 9) 
0 h 2.8 ± 0.7% 
24 h 5.0 ± 1.2% 
72 h 2.6 ± 1.0% 
96 h 5.3 ± 1.0% 
 
The percentage of apoptotic cells in the cortical region was counted per 100x field under a microscope. 
Data represent mean ± SEM with n ≥ 9.  
sli .  
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The ratio of apoptotic cells varied between 2.8% and 5.3% in HE staining, without 
significant increase over time (Table 4). Moreover, within the new slice coculture system 
and the sections from brain metastasis patients, tissues were also stained with specific 
markers for microglia, epithelial cells and astrocytes (Fig. 4.1.4). 
 
 
 
Fig. 4.1.4: Comparison of the new coculture system with human brain metastatic samples. To 
evaluate the distributions of microglia, astrocytes and tumor cells in the new coculture system (left panel) 
and to compare them with breast cancer brain metastasis samples (right panel), tissues were stained       
with HE (A1, A2). Staining was also performed employing anti-Iba1 and Kim1p antibodies for 
macrophages/activated microglia (B1, B2), antibodies against GFAP, as an astrocyte marker (C1, C2), and 
anti-pan cytokeratin (AE1/AE3), as a marker for epithelial cells (D1, D2). The reaction of the microglia 
and astrocytes in the new brain slice coculture model was found comparable to the human brain metastasis 
samples. 
 i t
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We observed the accumulation of microglia and astrocytes at the frontline of the tumor 
invasion in clinical samples from metastasis patients and at the border between the 
mouse brain slice and tumor plug (Fig. 4.1.4). By time lapse experiments, stromal cells 
were recorded to invade the (tumor-containing) cell plug and to make interaction with 
cancer cells, while, in turn, cancer cells also invaded the brain slice (see video 1). 
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4.2 Part B. Interaction between microglia and cancer cells 
 
4.2.1 Microglia co-localize and interact with tumor cells 
 
In video 1, recordings are suggestive of microglia actively interacting with the tumor 
cells. Confocal images of stained microglia and GFP-transfected tumor cells in the new 
coculture system confirmed this hypothesis. Microglial cells accumulated at the edge, 
right next to the tumor plug, indicating an active role in the invasion process (Fig. 
4.2.1A-C). In the brain slices, we observed invasions both by lone tumor cells (Fig. 
4.2.1D1-D3) and small colonies as accompanied by microglia. They also formed tight 
contacts with the tumor cells (either single cell or entire colonies), assuming a synapse-
like (Fig. 4.2.1E), palmate-like (Fig. 4.2.1F) or round morphology (Fig. 4.2.1G). Two 
microglial cells could also establish contact with each other by extending protrusions of 
up to 500 µm (Fig. 4.2.1H).  
 
Fig. 4.2.1: Microglia-tumor cell 
interaction in whole brain slice 
cocultures. Confocal microscopy 
images show GFP-transfected 
MCF-7 cells (green), microglia 
stained with ILB4-Alexa Fluor 568 
(red) and nuclei staining with DAPI 
(blue). (A) Frontline of tumor cells 
invading the brain slice. (B, C) 
Tumor cells and microglia cluster 
together within the slice. (D1-D3) 
A single tumor cell (white arrow) 
in direct contact with several 
microglial cells (yellow arrows). 
(E) A synapse-like contact between 
microglia and a single tumor cell. 
(F) A palmate-like contact between 
a microglial cell and two tumor 
cells. (G) Direct and complete 
contact between microglia and 
tumor cells. (H) Two microglial 
cells make contact through a 
protrusion extending for more than 
500 µm (some of the figures have 
been published in (Pukrop et al., 
2010). 
 
Fig. . . :  
interaction i  l  
cocultures.  
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4.2.2 The heterogeneity of microglia in the new coculture system 
 
Using the microglial cell surface carbohydrate-labeling lectin ILB4 in its fluoro dye- 
conjugated format, living microglia could be traced and investigated for the interaction 
with tumor cells for periods up to several days. Microglia showed heterogeneity in the 
new coculture system when interacting with tumor cells. In some cases, microglia served 
as transporters, helping a single cancer cell to move from one microglia to another until 
reaching the edge of the slice (see Fig. 4.2.2.1 and video 2). We called this process 
―microglia-assisted invasion‖ to distinguish the indirect effect of ―microglia-induced 
invasion‖ from the Boyden chamber experiments. 
Individual images from time-lapse microscopy show the phases of phenotype 
transformation as microglia interact with tumor cells (Fig. 4.2.2.2), which demonstrates 
that microglia assumed various morphologies—stellate (Fig. 4.2.2.2A, B), round (Fig. 
4.2.2.2C, I) or fiber-like (Fig. 4.2.2.2G, H)—most likely as an adaptation to changes in 
the microenvironment and most likely in support of functional orientations. Single 
microglial cell can interact with several tumor cells (Fig. 4.2.2.2B, D, and J), while a 
single tumor cell can also interact with multiple microglial cells (Fig. 4.2.2.2E, H). 
 
 
 
Fig. 4.2.2.1: Microglia acting as transporters in support of tumor invasion. Time-lapse microscopy 
showing cocultures of tumor cells with organotypic whole brain slices. Figures A1 through A6 show 
selected time points between 36 and 48 h. Video 2 records the whole sequences. Images show the region 
outside the brain slice and the tumor cell plug (green, GFP-transfected MCF-7 cells, and red, microglia 
(MG) stained with ILB4-Alexa Fluor 568). MG1 transports MCF-7 cells (T) to MG2 in the direction 
towards the brain slice. 
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Fig. 4.2.2.2: Morphology of microglia interacting with tumor cells. (A-J) Microglia undergo various 
morphological transformations during interaction with tumor cells. Images of the organotypic slice 
cocultures were taken with a time-lapse microscope (MG, microglial cells; T, MCF-7 tumor cells). 
 
4.2.3 Effects of microglia inactivation on cancer cell invasion 
 
At this point, it was essential to determine how important microglia are to cancer cell 
invasion. Therefore, microglia were depleted in the organotypic brain slices using a 
treatment with clodronate, a bisphosphonate. This procedure has been previously 
described (Dehghani et al., 2004). In addition, the effects of clodronate (applied at a 
concentration of 100 µg/ml) were evaluated for tumor cell viability, migration and 
invasion capacity (Fig. 4.2.3.1A-D). Clodronate inhibited microglia-induced MCF-7 
invasion in Boyden chamber assays without significantly hampering cell invasion as 
triggered by recombinant (r) Wnt5a, thus confirming the selectivity of the effect (Fig. 
4.2.3.1E).  
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Fig. 4.2.3.1: Effects of clodronate on microglia and tumor cells. (A, B) Influence of clodronate on 
microglia viability. (A) MTT conversion assay. Clodronate (100 μg/ml) does not significantly diminish the 
viability of MCF-7 and 410.4 tumor cells. (B) A flow cytometry analysis of calcein fluorescence (calcein-
positive = living cells). (C1-D2) Migration assay on ECM (phase contrast microscopy at indicated time 
points; gray line, start site). C1/C2 show the controls, and D1/D2 show clodronate-treated MCF-7 cells 
exhibiting identical migration patterns. (E) Clodronate (100 µg/ml) inhibits microglia-induced invasion, 
but does not hinder invasion triggered by rWnt5a (100 ng/ml). (F) Clodronate (100 µg/ml) reduces the 
microglia markers CSF1R and F4/80 in whole brain slices after 48 h of stimulation. Data represent mean ± 
SEM with n ≥ 9 (*p < 0.05; **p < 0.01; ***p < 0.001 compared to the control group). Some of the figures 
have been published in (Pukrop et al., 2010). 
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Time-lapse images confirmed that clodronate had an inactivation effect (Fig. 4.2.3.2A, 
B). Inactivating the microglia interfered with each step of the invasion process and 
resulted in less tumor invasion overall (see Fig. 4.2.3.2C1-D2; video 3a and 3b). 
Compared to the control group, clodronate significantly reduced the amount of MCF-7 
and M410.4 in the brain tissue (Fig. 4.2.3.2E, F). 
 
 
 
Fig. 4.2.3.2: Influence of clodronate on microglia and tumor cell invasion. (A, B) Images of 
organotypic whole brain slice cocultures, taken with time-lapse microscopy (green, GFP-transfected MCF-
7 cells; red, microglia, MG, stained with ILB4-Alexa Fluor 568). (A) In control slices, increasingly 
reactive microglia cells (white arrows) accumulate next to the tumor plug. Highly motile microglia (yellow 
arrow) move out of the slice. (B) In clodronate-treated slices, there is very little microglial accumulation, 
and microglia do not move out of the slice. (C1-D2) Time-lapse images of organotypic whole brain slice 
cocultures with MCF-7-GFP cells ± clodronate (100 µg/ml). Clodronate inactivates microglia and thus 
inhibits tumor cell invasion. (E, F) Quantification of cancer cell invasion in organotypic whole brain slice 
cocultures (see Materials and Methods, 3.14 for details). Data represent the percentage of the degree of cell 
invasion into brain slice in each group with n ≥ 8. E and F show that clodronate-treated slices reveal almost 
no invasion by either MCF-7 or 410.4 cells (*p < 0.05; **p < 0.01 compared to the control group). For more 
details and time-lapse sequences, see video 3a and 3b (some of the figures have been published in (Pukrop 
et al., 2010). 
     t cell invasi .
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4.2.4 Microglia assist invasion of malignant but not of immortalized non-
cancerous cells 
 
Next, microglia-induced cancer cell invasion was compared between the malignant cells 
(MCF-7) and an immortalized non-cancerous cell line (MDCK). The experiments 
showed that MCF-7 cells invaded the brain slices in both direct and indirect cocultures, 
while the MDCK cells did not (Fig. 4.2.4).  
 
 
 
Fig. 4.2.4: Microglia-induced and -assisted invasion of malignant cells but not of immortalized non-
cancerous cells. (A) We compared the degree of invasion by malignant MCF-7 and immortalized non-
cancerous MDCK cells in a modified Boyden chamber with or without microglia coculture. Data represent 
mean ± SEM with n ≥ 9 (***p < 0.001 compared to the control group). (B) We analyzed invasion by the 
MCF-7 and MDCK cells into the brain slice (see scoring in Material and Methods, 3.14). Data represent 
the percentage of the degree of MCF-7 or MDCK invasion into brain slice in each group with n ≥ 18 (*p < 
0.05 compared to the MDCK group). (C, D) Confocal images of whole brain slices in coculture with MCF-
7-GFP (green) and MDCK-GFP (green) cells. Microglia (MG) are stained with ILB4-Alexa Fluor 568 
(red). Nuclear staining with DAPI is blue. 
 
4.2.5 Tumor cells survive the brain slice’s defenses 
 
To clarify the different invasive behavior upon an encounter of the brain tissue with 
either malignant or immortalized non-cancerous cells, we performed a live-dead staining 
cells.  
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with a staining kit (Calcein AM-PI). With this assay system, we investigated cell plugs 
with immortalized non-cancerous MDCK and malignant MCF-7 cells in the presence and 
absence of adjacent organotypic brain slices. In the coculture experiments, plugs were 
evaluated at two different positions: position 1 (directly next to the brain slice) and 
position 2 (the opposing area) after 96 h (model scheme as seen in Fig. 4.2.5A).  
 
 
 
Fig. 4.2.5: Selective cytotoxic effects of the brain slice for immortalized cells. (A) Scheme of the 
experimental procedures, pos 1, position 1 (directly adjacent to the brain slice); pos 2, position 2 (on the 
contralateral side of pos 1 in the plug). (B) Results of the quantification by Image J software and box plots 
indicate the percentage of living cells compared to total cells. UV-irradiated cells served as a positive 
control (PC), and cell plugs alone were taken as untreated controls. (B) Both cell types were viable in the 
plugs (controls) and sensible to UV-treatment. The viability of MDCK cells was different at position 1 and 
2. By contrast, viability of MCF-7 cells in the control plug as well as both positions in the coculture with 
the brain slice did not vary significantly. Data represent mean ± SEM with n ≥ 9 (***p < 0.001, the 
comparison between pos 1 and pos 2). (C1-D2) Confocal images of MDCK and MCF-7 at both positions 
(PI, red, dead cells; calcein AM, green, living cells). 
i   
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There was no difference between the MDCK and MCF-7 plug alone (control) and 
position 2 in coculture with the organotypic brain slice. However, in position 1 only 33% 
of MDCK cells survived, in contrast to 90% in position 2 (
***
p < 0.001, Fig. 4.2.5B-D2). 
The MCF-7 viability did not vary significantly for the two positions and the control. The 
results indicate that the immortalized non-cancerous MDCK did not withstand the 
cytotoxic effect of the brain slice, whereas MCF-7 survived the attack of the brain slice, 
(see video 4a and 4b). 
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4.3 Part C. Signaling in microglia-assisted invasion  
 
4.3.1 Microglia-induced and -assisted invasion relies on Wnt and JNK 
 
In addition to the already known epithelial-mesenchymal transition (EMT) and other 
processes, microglia-assisted invasion may represent another mechanism for brain 
metastasis. Our lab previously found that Wnt5a and JNK pathways are important in 
macrophage-induced tumor invasion and that DKK1 can inhibit this coculture-induced 
invasion without affecting cell viability (Pukrop et al., 2006).  
 
 
 
Fig. 4.3.1: Dependence of microglia-enhanced invasion on Wnt and JNK. (A) Microinvasion assay. 
rDKK1 (200 ng/ml), sFRP-1 (400 ng/ml) and rDKK2 (200 ng/ml) reduced microglia-induced MCF-7 
invasion. Data represent mean ± SEM with n ≥ 9. (B) JNK inhibitor (JNK Inh, 5 µM) significantly reduced 
microglia-induced tumor invasion, while a negative control for JNK inhibitor (JNK NC, 5 µM) did not. 
Data represent mean ± SEM with n ≥ 9. (C) rDKK2 effectively hindered MCF-7 cells from invading 
organotypic whole brain slices. Data represent the percentage of the degree of MCF-7 invasion into brain 
slice in each group with with n ≥ 16 (**p < 0.01; ***p < 0.001 compared to the control group).  
 
To determine whether resident CNS microglia play the same role as peripheral blood-
derived macrophages, the physiological effects of Wnt inhibitors DKK1, DKK2, and 
secreted Frizzled-like protein-1 (sFRP-1) were examined. Cytotoxic effects of these 
factors on tumor cells and microglia could be excluded from studies performed before 
these experiments (data not shown). In a Boyden Chamber, microglia cocultures 
enhanced MCF-7 invasiveness (448%; 
***
p < 0.001), while rDKK1, rDKK2 and SFRP-1 
reduced microglia-induced invasion. Presence of rDKK2 almost completely eliminated 
coculture-induced invasiveness (154%, 
***
p < 0.001, Fig. 4.3.1A). Similar results were 
achieved by applying 5 µM of JNK inhibitor (140%, 
**
p < 0.01), as compared to the same 
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concentration of compound for the control sample (360%, Fig. 4.3.1B). Not only indirect 
coculture experiments, but also direct slice-tumor coculture experiments showed that 
rDKK2 effectively antagonized the invasiveness (
**
p < 0.01, Fig. 4.3.1C). rDKK1 
produced a similar effect, yet without reaching statistical significance. 
 
4.3.2 Microglia express endogenous Wnt-related genes 
 
To identify potential Wnt ligands as candidates for these inhibitory mechanisms, we 
examined the endogenous expression of Wnts in primary microglia. As shown in Fig. 
4.3.2, microglia express several Wnt ligands and inhibitor genes. However Wnt5a, Wnt6 
and DKK2 had the highest expression levels. In contrast to the macrophages, microglia 
constitutively express several Wnt ligands without showing any change in regulation 
upon cocultivation (data not shown). 
 
 
 
Fig. 4.3.2: Expression of Wnt genes in primary microglia. 25 ng of cDNA from primary microglial cells 
and qRT-PCR was used to examine the endogenous Wnt-related gene expressions in primary microglial 
cells and cycle threshold (Ct) values were obtained. A bar chart represents each data in a gene as one bar 
with n ≥ 6. Microglia (MG) express Wnt-related genes, with Wnt5a, 6 and DKK2 showing the highest 
levels. Microglial cells have moderate Wnt3, Wn4, Wnt5b, Wnt7a, Wnt9a, Wnt9b, Wnt10a, Wnt10b, 
Wnt11, Wnt16 expressions, while Wnt1, Wnt3a, Wnt5b and DKK3 are almost completely absent.  
 
4.3.3 Wnt5a deficiency reduces tumor invasiveness 
 
To determine whether Wnt5a―one of the potential candidates with microglia as its 
source in the brain microenvironment―affects cancer cell invasion, brain slices from 
Wnt5a
+/-
 heterozygous mice were employed. It is noteworthy that in these brain slices, 
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tumor invasiveness was significantly reduced (Fig. 4.3.3). Taken together, these results 
confirm that Wnt signaling, especially Wnt5a, is essential for tumor cells to invade and 
colonize brain tissue. 
 
Fig. 4.3.3: Effect of Wnt5a on tumor invasion. 105 of MCF-7 cells 
and brain slices from the different Wnt5a genotypes in an organotypic 
whole brain slice were cocultured for 96 h. Coculturing MCF-7 cells 
with whole brain slices from Wnt5a knockout (heterozygous knockout, 
Wnt5a+/-) mice resulted in markedly less invasiveness as compared to 
wildtype slices (Wnt5a+/+). The invasion of MCF-7 cells was evaluated 
as described in the former figures (see scoring in Materials and 
Methods, 3.14). Data represent the percentage of the degree of MCF-7 
invasion into brain slice in each group with n ≥ 20 (**p < 0.01 
compared to the Wnt5a+/+ group). 
 
 
4.3.4 Characterization of proinvasive microglia and confirmation of the Wnt 
signaling role 
 
Parallel to the above mentioned results, we also performed experiments to categorize 
cocultured microglia as to proinflammatory (M1) versus anti-inflammatory (M2) 
phenotypes. To our astonishment, cocultures with either M410.4 or MCF-7 did not 
change the microglia cytokine and chemokine profile, as compared to controls. To test 
whether microglia could be activated by a pro-inflammatory stimulus, LPS stimulation 
was applied. Indeed, LPS triggered a proinflammatory phenotype in microglia and 
reduced microglia-induced tumor invasion in Boyden chamber experiments (Fig. 4.3.4A).  
To describe the LPS effect in more detail and to clarify whether it was Wnt-
related, we performed indirect coculture experiments with MCF-7 for 24 h. The 
following conditions were investigated: (i) microglia; (ii) microglia + LPS; (iii) microglia 
+ MCF-7; (iv) microglia + MCF-7 + LPS. The RNA of the microglia was isolated with 
TRIZOL and prepared according to manufacturer’s protocol (see also Materials and 
Methods, 3.15). Afterwards, the quality of RNA was proven before it was used for 
hybridization of the murine 4 x 44K whole genome arrays. A threshold was established 
for data selection, by a more than 2-fold change of gene regulation and a p value less 
than 0.05. Results are shown below (Fig. 4.3.4). MCF-7 cocultures did not significantly 
affect gene expression in microglia (Fig. 4.3.4B, i versus ii). Exposing tumor-instructed 
microglia to LPS resulted in the regulation of 5.163 genes (Fig. 4.3.4C, ii versus iv). By 
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contrast, more than 400 genes were regulated in LPS-instructed microglia ± coculture 
with MCF-7 cells (data not shown). Pathway analysis by Panther of these 400 genes 
(www.pantherdb.org) confirmed that Wnt signaling was under the five most regulated 
pathways. Interestingly, a previously described target of Wnt5a, i.e. the CXCR4 gene, 
was the most strongly regulated gene (more than 32 fold, data not shown), when tumor 
cells were exposed to inflammatory microglia. Ghosh and colleagues have recently 
demonstrated that CXCR4 is a target of Wnt5a in T cells, which regulates directional 
migration as mediated by CXC chemokine ligand 12 (CXCL12, also known as stroma-
derived factor, SDF-1), a ligand of CXCR4 (Ghosh et al., 2009). 
 
 
 
Fig. 4.3.4: Influence of tumor cell coculture on microglia phenotype and gene expression. (A) Non-
contact microinvasion assay. LPS stimulation at a concentration of 100 ng/ml hindered microglia (MG)-
induced invasion. Data represent mean ± SEM with n ≥ 9 (***p < 0.001 compared to the LPS-treated group 
and MG-cocultured group, respectively). (B, C) Whole genome arrays of microglia. Results are shown as 
effect plots with the 2x-fold gene up-/down-regulation on the x-axis and the corresponding p-value on the 
y-axis. (B) Coculture with MCF-7 did not significantly change gene expression. (C) Adding LPS to 
cocultured microglia induced regulation of a multitude of genes, 5.163 of which had a p value of less than 
0.05 (this figure has been published in (Pukrop et al., 2010). 
 
4.3.5 Role of CXCR4 as a known target of Wnt signaling in microglia-
induced tumor invasion 
 
Our whole genome array showed that CXCR4 was an interesting candidate to regulate 
microglia-induced invasion. First, selected qRT-PCR tests were performed to confirm the 
former result (Fig. 4.3.5.1A). To study the relationship between CXCR4 and Wnt 
signaling pathways, we added the Wnt inhibitors to indirect coculture experiments. Both 
of the tested Wnt inhibitors, DKK1 and DKK2, reduced the level of CXCR4 gene 
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expression in microglia when being exposed to tumor cells (Fig. 4.3.5.1B). Interestingly, 
CXCR4 gene expression was not affected in MCF-7 cells, neither by a coculture with 
microglia nor by additional DKK1 and DKK2 stimulation (data not shown). Coculturing 
also did not affect the expression of the ligand for CXCR4, i.e. SDF-1 (CXCL12), in 
either microglia or MCF-7 cells (data not shown). To further investigate the 
physiological effects of CXCR4 on tumor progression, we applied the CXCR4 inhibitor 
AMD3100 in our new coculture assay, first ruling out its cytotoxic effects on tumor cells 
and microglia (Fig. 4.3.5.1C). In a non-direct contact coculture, application of 1 µg/ml of 
AMD3100 inhibited microglia-induced tumor invasion (Fig. 4.3.5.1D). 
 
 
 
Fig. 4.3.5.1: Relationship between CXCR4, Wnt signaling and tumor invasion. (A) Our gene array 
data showed CXCR4 to be the gene most regulated by cancer cells in inflammatory conditions. qRT-PCR 
tests confirmed this finding (∆Ct = Ct, gene of interest [GOI] – Ct, housekeeping gene [HK]). (B) DKKs 
down-regulated CXCR4 gene expression in microglia. (C) MTT conversion assay. The CXCR4 inhibitor 
AMD3100 did not significantly diminish tumor cell viability at a concentration of 1 μg/ml. (D) The 
application of AMD3100 (1 μg/ml) to a microinvasion assay, however, reduced microglia-induced MCF-7 
invasion. Data represent mean ± SEM with n ≥ 9 (*p < 0.05; **p < 0.01; ***p < 0.001 compared to the 
control groups). 
        
 
. . . .    ,     i i . 
4. Results 
 
55 
 
Furthermore, we tested for CXCR4 protein expression in microglia and MCF-7 cells 
using Western blot experiments and found that both expressed this protein (Fig. 
4.3.5.2A). Fig. 4.3.5.2B shows that CXCR4 localized to the nucleus of microglial cells. 
We compared the level of CXCR4 expression to a control group with 10 ng/ml of IL-10 
treatment, which has been shown to up-regulate CXCR4 expression in macrophages 
(Ancuta et al., 2001). From our gene data, we knew that LPS could dramatically down-
regulate CXCR4 gene expression. IL-10, therefore, served as a positive control, while 
LPS served as a down-regulation control. However, both the immunofluorescence 
staining and flow cytometry methods did not reveal differences between any of the 
treatments tested. Fig. 4.3.5.2C shows a representative histogram of three independent 
experiments. 
 
 
 
Fig. 4.3.5.2: CXCR4 protein expression in microglia and MCF-7 cells. (A) Primary microglial cells and 
MCF-7 cells express endogenous CXCR4 proteins as demonstrated by immunoblotting. (B) LPS 
stimulation does not affect microglial CXCR4 protein expression as revealed by immunocytochemistry. (C) 
Neither IL-10 nor LPS stimulation for 24 h affect microglial surface CXCR4 protein expression as 
analyzed by flow cytometry. Data were normalized and shown as percentage of maximum (% of max, see 
Materials and Methods, 3.20 for details). Representative data are out of three independent experiments, 
with no significant differences being evident. 
 
To answer the question of whether CXCR4 is necessary for microglia-assisted tumor 
invasion, we applied the CXCR4 inhibitor AMD3100. This inhibited colonization of 
brain tissue by MCF-7 cells in organotypic brain slice cocultures (see Fig. 4.3.5.3A, B; 
video 5a and 5b). The results indicate that CXCR4 is a target of Wnt signaling and that it 
is critical for invasion and colonization of the CNS tissue by cancer cells. 
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Fig. 4.3.5.3: Effect of AMD3100 on tumor invasion. (A) AMD3100 (1 μg/ml) inhibited the MCF-7 
colonization in brain tissue in an organotypic brain slice coculture. Data represent the percentage of the 
degree of MCF-7 invasion into brain slice in each group with n ≥ 14 (***p < 0.001 compared to the control 
group). (B1, B2) Confocal microscopy images confirmed this effect (green, GFP-transfected MCF-7 cells; 
red, microglia stained with the ILB4-Alexa Fluor 568; blue, nuclear staining with DAPI).  
 
4.3.6 LPS regulates Wnt genes in microglia  
 
To confirm the effects of LPS and tumor coculture on Wnt-related genes in microglia, we 
performed qRT-PCR analysis (Fig. 4.3.6). LPS affects several Wnt-related genes in 
microglia, resulting in an up-regulation of Wnt6 (42-fold) and down-regulation of Wnt5b 
and DKK2 (Fig. 4.3.6). When cocultured, however, microglia did not show any change 
in regulation of Wnt ligands. 
 
 
 
Fig. 4.3.6: Effect of LPS and tumor coculture on Wnt gene expression in primary microglial cells. 
Adding LPS down-regulated Wnt5b and DKK2 and up-regulated Wnt6, while coculturing the microglia 
with MCF-7 cells slightly down-regulated DKK1 and DKK2, but none of the ligand genes in microglial 
cells are regulated. The values are shown as the log2 of the fold change calculated with the 2
-ΔΔCT method 
with n ≥ 9 (*p < 0.05; ***p < 0.001 of MG ± LPS; # p < 0.05 of MG ± MCF-7 coculture). 
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4.4 Part D. TLR signaling in microglia-assisted invasion  
 
4.4.1 LPS induces an anti-invasive phenotype in microglia via TLR4 
 
In addition to Wnt signaling pathways, comparing LPS-instructed microglia ± coculture 
with MCF-7 cells revealed that TLR pathways were also among the five most regulated 
pathways influenced by cancer cells. TLRs are known to play important roles in the 
innate immune system and beyond. The exact relationship between TLR signaling and 
tumor progression is less understood, but has begun to draw broad attention.  
    
 
 
Fig. 4.4.1: Effects of various TLR agonists on tumor invasion. (A) 1 µg/ml of LPS or Pam3CSK4 had no 
cytotoxic effects on MCF-7 cells, M410.4 cells and microglia. (B) The TLR4 agonist LPS (100 ng/ml) 
reduced microglia (MG)-induced tumor invasion in a microinvasion assay, but the TLR1/2 agonist 
Pam3CSK4 (100 ng/ml) did not. Data represent mean ± SEM with n ≥ 6 (
***p < 0.001 compared to the MG-
cocultured group). (C) 1 µg/ml of LPS reduced MCF-7 invasion into organotypic whole brain slice, while 
Pam3CSK4 did not. (D) Anti-invasive effects of LPS are shown in coculture with murine M410.4 cells. 
Data represent the percentage of the degree of MCF-7 invasion into brain slice in each group with n ≥ 12 
(*p < 0.05; **p < 0.01 compared to the control group). 
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Different ligands activate the TLR signaling pathways through the MyD88 and TRIF. 
Among the TLRs, TLR4 signaling is unique because it activates both adaptor proteins, 
MyD88 and TRIF. TLR3 signals via TRIF, while the remaining TLRs activate MyD88. 
To investigate the difference between TLR4 and other TLRs in tumor invasion, we 
applied the TLR4 agonist LPS and the TLR1/2 agonist Pam3CSK4 in the microinvasion 
assay and organotypic whole brain slice coculture system. The concentration used (1 
µg/ml) did not show cytotoxic effects on the MCF-7, M410.4 and microglial cells (Fig. 
4.4.1A). The invasion capacity of MCF-7 was also not influenced (see Fig. 4.3.4A). In 
contrast, we found that the TLR4 agonist reduced the tumor invasion in both indirect 
(Fig. 4.4.1B) and direct (Fig. 4.4.1C) slice-tumor cocultures, while the TLR1/2 agonist 
did not. Anti-invasiveness effects of LPS are shown for both murine M410.4 and human 
breast cancer cells (Fig. 4.4.1 C, D). 
 
4.4.2 MyD88 plays an important role in tumor invasion 
 
To investigate the role of the TLR signaling adaptors MyD88 and TRIF in tumor 
progression, we used microglia or brain slices that were deficient in either of the two 
molecules. We eliminated the tumor-inducing effects of microglia by using microglia 
isolated from MyD88-deficient mice (Fig. 4.4.2A). Tumor cells have less invasion ability 
when encountering the MyD88-deficient microenvironment, as was proven by 
coculturing the MCF-7 cells with brain slices being heterozygous and homozygous by 
MyD88 deficiency (Fig. 4.4.2B, C). In addition, the anti-invasive effects of MyD88-
deficient brain slices were partially rescued by addition of microglia from the wildtype 
strain (Fig. 4.4.2B, for details about the rescue experiment see Materials and Methods, 
3.7.3). Further LPS stimulation reversed this rescue effect. The results above suggest that 
the presence of MyD88 in the microenvironment plays an important role in favor of 
tumor progression, particularly when being functional in microglia. Images from time 
lapse microscope show the different levels of tumor invasion found with MyD88
+/+
 and 
MyD88
-/-
 brain slices (see video 6a and 6b).  
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Fig. 4.4.2: Effects of MyD88 on tumor progression. (A) Cocultures of microglia (MG) from different 
genotypes of MyD88 mice (+/+, wildtype; +/-, heterozygous; -/-, homozygous knockout) in the 
microinvasion assay. Data represent mean ± SEM with n ≥ 8 (*p < 0.05 compared to the MyD88+/+ group). 
(B) MCF-7 cells and brain slices from the different genotypes in an organotypic whole brain slice coculture 
after 96 h. Data represent the percentage of the degree of MCF-7 invasion into brain slice in each group 
with n ≥ 19 (*p < 0.05; **p < 0.01; ***p < 0.001, the comparison between different groups). Brain slices 
from MyD88 knockout mice reduced the invasiveness of tumor cells. This effect was partially rescued in 
cocultures with wildtype microglia and reversed by LPS again. (C1, C2) Confocal images of MCF-7 cells 
cocultured with MyD88 wildtype (MyD88+/+) and MyD88 homozygous knockout (MyD88-/-) brain slices 
(green, GFP-transfected MCF-7 cells; red, microglia stained with ILB4-Alexa Fluor 568; blue, nuclear 
staining with DAPI). 
 
4.4.3 TLR4-deficient brain slices exhibit less tumor invasion 
 
As stimulation with the TLR4-agonist LPS produced an anti-invasive phenotype, we 
used organotypic brain slice-MCF-7 cocultures with slices from TLR4-deficient mice to 
study the role of TLR4 in tumor invasion. Coculturing tumor cells with brain slices from 
TLR4 homozygous knockout (TLR4
-/-
) mice, indeed, resulted in markedly less tumor 
invasion. Fig. 4.4.3 confirms that TLR4 played a direct and important role in tumor 
invasion. This observation is not trivial. Although we found the dependence on MyD88 
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signaling in general and its importance in microglia in particular, several TLRs use this 
adaptor pathway for their signaling. It is thus an important finding that TLR4, among the 
TLR family members, is itself a sensitive signaling element for successful tumor 
progression. Yet the mechanism of blockade by experimental TLR4 activation―at first 
glance a paradoxical phenomenon―required further investigation.  
 
 
 
Fig. 4.4.3: Role of functional TLR4 in tumor progression. (A) Cocultures of MCF-7 cells and whole 
brain slices from wildtype or homozygous TLR4 knockout (TLR4-/-) mice revealed that invasiveness of 
MCF-7 cells was less in TLR4 knockout mice than in the wildtype setting. Data represent the percentage of 
the degree of MCF-7 invasion into brain slice in each group with n ≥ 31 (***p < 0.001 compared to the 
TLR4+/+ group). (B1, B2) Images are taken by confocal microscopy (green, GFP-transfected MCF-7 cells; 
red, microglia as stained with ILB4-Alexa Fluor 568; blue, nuclear staining with DAPI). 
 
4.4.4 TRIF is important for the protective effect of LPS 
 
 Deficiencies of TLR4 and the adaptor MyD88 both produce an anti-invasive effect. 
Thus, TLR4→MyD88 signaling would endogenously promote invasion. In sharp 
contrast, a further stimulation by exogenous LPS would rather reverse the outcome to 
inhibition. A conceivable explanation could rely on the dual signaling capacity of TLR4, 
suggesting that the MyD88 limb would primarily support tumor invasion, while an 
activation of TRIF or both MyD88 in combination with TRIF could cause the opposite 
effect. 
To evaluate the role that TRIF, as the second adaptor in TLR4 signaling, plays for 
tumor invasion, the same protocol was repeated based on TRIF-deficient mice. 
Importantly, the degree of MCF-7 invasiveness for brain slices with a heterozygous TRIF 
deficiency (TRIF
+/-
) did not vary much from the wildtype situation. However, in a full 
knockout environment, in brain tissue of homozygous background (TRIF
-/-
), tumor cells 
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apparently enjoyed even more support. This may indicate that endogenous TRIF 
signaling activity to some extent counteracts the invasion and that absence of any TRIF 
would worsen the outcome for the CNS, namely the tumor burden. In agreement with an 
assumed anti-tumor invasion role of TRIF, the anti-invasive effect of LPS in TRIF-
deficient brain slices was only mild and even not significant (Fig. 4.4.4). Adding 
wildtype microglia into the tumor plug partially rescued the protective LPS effect by 
externally introducing TRIF-competent microglia. Thus, in contrast to MyD88, TRIF 
most likely has a protective anti-tumor effect in response to LPS stimulation, particularly 
in truly resident microglia.  
 
 
 
Fig. 4.4.4: Role of TRIF in tumor progression. (A) MCF-7 cells cocultured with brain slices from mice 
with different genotypes regarding TRIF (+/+, wildtype; +/-, heterozygous deficiency; -/-, homozygous 
deficiency). Data represent the percentage of the degree of MCF-7 invasion into brain slice in each group 
with n ≥ 15 (*p < 0.05 compared to the TRIF-/- group). (B1, B2) Images as captured with confocal 
microscopy at 25x magnification (green, GFP-transfected MCF-7 cells; red, microglia stained with ILB4-
Alexa Fluor 568; blue, nuclear staining with DAPI). 
 
4.4.5 INFβ alone is not sufficient to inhibit microglia-assisted invasion 
 
With the important finding that the anti-invasive effect of LPS seemed to largely rely on 
the TRIF-dependent pathway―or its assistance in a TLR4 signaling also requiring 
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MyD88―the next question arose whether an individual downstream effector could be 
defined. In principle, it would come to an inducible gene or gene set relying on the 
functional TRIF. Theoretically, such identifiable gene products could be targets of a 
prospective therapeutic interference with cancer spread. Considering downstream 
pathways and targets that are governed by TRIF, the best-characterized factor is IFNβ, 
which belongs to the type I IFNs and is important for antiviral responses. In order to 
evaluate the role of IFNβ in microglia-induced tumor invasion, we applied mouse 
recombinant IFNβ at 100 ng/ml to stimulate organotypic brain slice cocultures. However, 
there was no significant difference in tumor invasion (Fig. 4.4.5).  In other words, even 
though IFNβ is the most prominent outflow of the TRIF route, it does not appear to be 
the essential element in the anti-invasive action. 
 
Fig. 4.4.5: Effect of IFNβ on tumor progression. IFNβ (100 ng/ml) 
was applied to organotypic whole brain slice cocultures with 105 
MCF-7 cells for 96 h. The invasion of MCF-7 cells was evaluated as 
described in the former figures (see scoring in Material and Methods, 
3.14). Data represent the percentage of the degree of MCF-7 invasion 
into brain slice in each group with n = 16. 
 
 
 
 
4.4.6 Poly (A:U) as an agonist for TLR3 is also not sufficient to inhibit 
microglia-assisted invasion 
 
Since our results showed a protective effect of TRIF in response to LPS stimulation, we 
were particularly interested in TRIF activation by other receptors. Among the TLR 
family and beyond, TLR3 is the only receptor known thus far to activate TRIF alone. In 
contrast to TLR4, it relies on this adaptor without contributions from MyD88. TLR3 and 
thus TRIF stimulation were achieved by applying 100 µg/ml of poly (A:U), a double-
stranded RNA that has previously been shown to activate TLR3 (Conforti et al., 2010). 
Although poly (A:U) is not absolutely restricted to TLR3 (as it activates also a retinoic 
acid-inducible gene-like molecule, known as melanoma differentiation-associated gene 
5/MDA5), we chose this ligand for our experiments on the assisted tumor invasion, since 
other, alternative ligands do not offer much more selectivity (data not shown). 
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Nevertheless, our results did not show a significant difference in microglia-assisted 
tumor invasion (Fig. 4.4.6). 
 
 
Fig. 4.4.6: Effect of TLR3 activation by poly (A:U) on the tumor 
progression. 100 µg/ml of poly (A:U) was applied to organotypic 
whole brain slice cocultures with 105 MCF-7 cells for 96 h. The 
invasion of MCF-7 cells was evaluated as described (see scoring in 
Material and Methods, 3.14). Data represent the percentage of the 
degree of MCF-7 invasion into brain slice in each group with n = 16. 
 
 
 
 
 
The results of the poly (A:U) stimulation demonstrate that activating TRIF signaling is 
not sufficient to achieve a protective effect. The protective LPS effect seems to be less a 
pure qualitative effect (TRIF or MyD88) than a quantitative one (a balance between 
TRIF and MyD88). If this hypothesis is correct, the protective targets of LPS have to be 
under the control or influence of both adaptor proteins. From the literature, we identified 
NO as an interesting candidate as its production by inducible NO synthase (iNOS) is 
often reported to be regulated via NF-B, a transcription factor system under the control 
of both MyD88 and TRIF (Tumurkhuu et al., 2010). The concerted, partially sequential 
activation of NF-B by the two pathways is still subject to intense research as the 
regulation appears to be complex. 
 
4.4.7 NO production is an important target of LPS via both TRIF- and 
MyD88-dependent pathways 
 
NO has been known long before and was first described in 1990 for its role in 
vasodilatation. More recently, some publications have also described NO in conjunction 
with tumor progression (Fukumura et al., 2006). To address NO and its regulation by 
TRIF and MyD88, we first examined its release by microglia upon TLR4 and TLR1/2 
stimulation. The release of the short-lived NO was determined as nitrite accumulation. 
Results showed that LPS induced nitrite production, while an increase by TLR1/2 agonist 
was not measurable (Fig. 4.4.7A). However, the NO-inducing effect of LPS disappeared 
in homozygous knockout microglia cells from MyD88 (MyD88
-/-
), TRIF (TRIF
-/-
) and 
. . : E fect of TLR3 activation by poly (A:U) on 
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TLR4 (TLR4
-/-
) strains (Fig. 4.4.7A). In terms of iNOS gene expression, MyD88, TRIF
 
and TLR4
 
all exhibited importance for the LPS-mediated induction. TRIF thereby 
contributed more than MyD88 to iNOS mRNA synthesis (Fig. 4.4.7B). Interestingly, 
when stimulated with synthetic double-stranded RNAs, such as poly (A:U), nitrite 
production did not change compared to the control group (data not shown). These 
findings indicate that NO is mainly regulated via TRIF activation, though with crucial 
assistance from MyD88.  
 
 
 
Fig. 4.4.7: TLR4 and TLR1/2 agonist-induced NO production by microglia. (A) Microglia (MG) from 
different homozygously deficient mice (wildtype, TLR4-/-, MyD88-/- and TRIF-/-) releasing NO as 
measured by nitrite accumulation. Cells were stimulated with LPS (100 ng/ml) or Pam3CSK4 (100 ng/ml) 
and nitrite levels were measured in the supernatant. (B) Microglia from different strains of mice with or 
without LPS (100 ng/ml) stimulation for 24 h were processed to isolate RNA for iNOS gene expression 
analysis using qRT-PCR tests. Data represent mean ± SEM with n ≥ 6. 
 
4.4.8 The biphasic role of NO in tumor progression 
 
Recently, it was shown that NO played a biphasic role for macrophages in tumor 
progression (Weiss et al., 2010). According to this study, in a low NO atmosphere, 
applying an NO inhibitor reduces tumor growth, while in a high NO atmosphere, the 
application of an NO donor improves survival rates. This underlines our hypothesis that 
the protective effect is quantitative. 
 To determine the effects of NO on tumor progression, we used the NO synthase 
inhibitor N
ω
-nitro-L-arginine methyl ester (L-NAME) and the NO donor S-nitroso-N-
acetyl-D, L-penicillamine (SNAP). First, we investigated the influence of both on the NO 
release in microglia. Applying L-NAME at a concentration of 1 mM effectively 
decreased the concentration of nitrite (45 ± 12%) in microglial supernatants, while 
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concentrations of 100 µM and 1 mM inhibited LPS-induced NO release (Fig. 4.4.8A). By 
comparison, 50 to 100 µM of SNAP boosted nitrite by a level comparable to the effects 
of 100 ng/ml LPS. The chosen concentrations of L-NAME and SNAP were not cytotoxic 
for microglia, while SNAP at 50 µM slightly reduced the ability of MTT conversion by 
MCF-7 cells (91 ± 8%) and 100 µM (80 ± 7%).  
 
 
 
Fig. 4.4.8: Effects of L-NAME and SNAP on NO release (nitrite levels) and MTT conversion. (A) 
Nitrite levels were measured in microglia supernatants and normalized to the data from control groups. (B) 
MTT conversion assay. L-NAME and SNAP do not significantly diminish the viability of microglial cells, 
but the chosen concentration of SNAP slightly decreased MCF-7 viability. Data represent mean ± SEM 
with n ≥ 6 (*p < 0.05 compared to the control group). 
 
4.4.9 NO inhibitor and donor compounds both reduce tumor invasion 
 
Even knowing that the NO donor SNAP might influence the viability of the MCF-7 cells, 
we used SNAP and the NO inhibitor L-NAME to stimulate brain slices cocultured with 
MCF-7.  As expected, SNAP (50-100 µM) produced an anti-invasive phenotype with 
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statistical significance (Fig. 4.4.9A). Interestingly, we also observed a significant 
increase of apoptotic cells in the brain slice, but not within the tumor plug (Fig. 4.4.9B). 
Unexpectedly, the inhibitor L-NAME (at concentrations of 100 µM) reduced 
invasiveness (Fig. 4.4.9A). Knowing from previous results that the MCF-7 cells produce 
only small amounts of NO and show low iNOS expression (data not shown), we 
speculated that the L-NAME effect was due to elements in the brain slice, particularly 
the resident microglia. Interestingly, we confirmed that NO at low concentrations was 
necessary for cancer cell invasion, whereas high concentrations were toxic for cancer 
cells, but not for microglia.  
 
 
 
Fig. 4.4.9: NO inhibitor and NO donor effects on tumor progression. (A) The NO synthase inhibitor L-
NAME (100 µM) and the NO donor SNAP (50 µM and 100 µM) were applied to organotypic whole brain 
slice-MCF-7 cocultures for 96 h, with repeated administration every second day. The invasion of MCF-7 
cells was evaluated as described in the former figures (see scoring in Material and Methods, 3.14). Data 
represent the percentage of the degree of MCF-7 invasion into brain slice in each group with n ≥ 11 (*p < 
0.05; ***p < 0.001 compared to the control group). (B) SNAP resulted in many apoptotic MCF-7 cells. The 
image shows an apoptotic cell being enveloped by a microglial cell through phagocytosis (green, GFP-
transfected MCF-7 cells; red, microglia stained with ILB4-Alexa Fluor 568; blue, nuclear staining with 
DAPI). 
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4.4.10 cGMP as a classical NO target reduces microglia-assisted invasion 
 
To clarify whether elevated levels of NO could really mitigate microglia-assisted 
invasion, we searched for a downstream target of NO, ideally without toxic effects on 
tumor cells and microglia. Classical NO signaling involves the activation of soluble 
guanylyl cyclase (sGC), generation of cyclic GMP (cGMP) and subsequently the 
activation of cGMP-dependent protein kinase (PKG), as a cGMP-dependent pathway. 8-
bromo-guanosine 3', 5'-cyclic monophosphate (8-Br-cGMP), as an established 
membrane-permeable analog of the natural signal molecule cGMP, acts as a potent 
agonist for the cGMP-dependent pathway. Compared to cGMP, cyclic nucleotide-
dependent phosphodiesterase degrades 8-Br-cGMP much slower (Siednienko et al., 
2011). We first tested different concentrations of 8-Br-cGMP for cytotoxic effects on 
MCF-7 and microglia (Fig. 4.4.10.1). Interestingly, the MCF-7 and microglial cells 
exhibited opposite reactions in the MTT assay. The reaction of microglia increased, 
while MCF-7 decreased, at high concentrations. This may not only relate to viability per 
se, but to the activity of the MTT conversion, suggesting that increases come with 
increased metabolic activity. Importantly, however, the effect was comparable to the NO 
donor stimulation. 
 
 
 
Fig. 4.4.10.1: Effect of cGMP on tumor cells. 0 to 100 µM of 8-Br-cGMP were applied to 105 microglia 
and MCF-7 cells for 96 h and the cell viability was subsequently evaluated with a MTT conversion assay. 
Applying 8-Br-cGMP did not significantly diminish the viability of microglia and MCF-7 cells at the 
chosen concentration (10 µM). Data represent mean ± SEM with n ≥ 6 (*p < 0.05 compared to the control 
group). 
 
To avoid direct cytotoxicity, we applied 10 µM of 8-Br-cGMP to the brain slice 
cocultures. This stimulation significantly reduced invasion by MCF-7 cells into the brain 
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slices (Fig. 4.4.10.2), indicating that cyclic GMP has the capacity to affect tumor 
invasion.  
 
Fig. 4.4.10.2: Effect of cGMP on tumor cell invasion. 8-bromo cGMP 
(10 µM) was applied to organotypic whole brain slice cocultures with 
105 MCF-7 cells for 96h. The invasion of MCF-7 cells was evaluated as 
described (see scoring in Material and Methods, 3.14). Treating cells 
and slices with 8-Br-cGMP significantly reduced tumor invasion in 
organotypic whole brain slice cocultures. Data represent the percentage 
of the degree of MCF-7 invasion into brain slice in each group with n ≥ 
7 (*p < 0.05 compared to the control group). 
 
 
Taking all the TLR-related results together, we demonstrated that MyD88 is important 
for microglia-assisted invasion and that TRIF is crucial for producing a protective effect 
in response to LPS stimulation. The balance between these two adaptors is important 
because the missing effect of MyD88 in tumor invasion and the missing TRIF protective 
effect can be rescued with additional microglia from wildtype mice. Only stimulation 
with TLR3 or a direct downstream target thereof did not produce a protective effect, 
while targets of both TRIF and MyD88 regulation, such as NO, could be crucial during 
tumor invasion depending on how the activities of the two pathways are balanced. 
Research in the past has recorded the biphasic effect of NO on tumor progression. 
Indeed, the anti-invasive effect of LPS is an effect through TRIF and MyD88 and might 
depend on the balance of NO in the microenvironment. 
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4.5 Part E. Cross links between Wnt and TLR in microglia-assisted 
invasion 
 
4.5.1 LPS regulates Wnt genes in microglia  
 
As the whole genome results had indicated a direct link between Wnt and TLR signaling, 
we performed qRT-PCR experiments to confirm the effects of TLR activation on Wnt-
related genes in microglia. TLR4 and TLR1/2 activation affected several Wnt-related 
genes in microglia, while IFNβ activation did not (Fig. 4.5.1) 
 
Fig. 4.5.1: Effects of TLR activation on Wnt-
related gene expression. LPS and Pam3CSK4 had 
regulatory effects on Wnt6 and DKK2 genes in 
microglia, while IFNβ did not. The values are 
shown as the log2 of the fold change calculated 
with the 2-ΔΔCT method with n ≥ 6. 
 
 
 
 
 
4.5.2 Both TRIF and Myd88 contribute to the regulatory effect of LPS on 
Wnt-related gene expression, while TRIF plays a particularly important role 
 
To clarify whether both TRIF and MyD88 control the effects of TLR activation on the 
expression of Wnt-related genes in microglia, we compared the regulatory effect of LPS 
on microglia from wildtype, MyD88-deficient, TRIF-deficient and TLR4-deficient mice. 
Results revealed that both TRIF- and MyD88-deficient microglia changed the effects of 
LPS on Wnt-related genes. Microglia from TLR4-deficient strains saw almost no LPS 
regulatory effect, including up-regulation of Wnt6 and down-regulation of Wnt5b, DKK2 
and CXCR4. The TRIF adaptor was more important for the effects of LPS on Wnt5b, 
Wnt6 and DKK2, while MyD88 adaptor was more important for the effects on CXCR4. 
  activati  on nt-
. 
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Fig. 4.5.2: Role of Wnt and TLR4 signaling pathways in LPS regulated effects. Microglia deficient in 
TLR4, MyD88 or TRIF show a loss of regulatory effects of LPS on Wnt5a, Wnt6, DKK2 and CXCR4. The 
values are shown as the log2 of the fold change calculated with the 2
-ΔΔCT method with n ≥ 6. 
 
4.5.3 Wnt-related genes also regulate LPS-induced NO release  
 
The results above indicate a direct link between Wnt and TLR signaling and show that 
TLR activation affects Wnt-related gene expression. It remained to be determined, 
however, whether Wnt activation also influences TLR-related gene expression. We have 
shown previously that NO release strongly depends on TRIF, MyD88 and TLR4 
activation (see Fig. 4.4.7). We used LPS to induce NO release and to investigate how 
Wnt signaling or its lack would affect NO release. SB-216763 serves as a GSK-3 
inhibitor and can activate Wnt signaling. LPS boosted the release of NO, expressed as 
nitrite, while SB-216763 alone also showed an increase in nitrite. Pretreatment with SB-
216763 for 4 h significantly reduced the boost in NO release as caused by LPS. We 
demonstrated that Wnt signaling affects the release of NO, which was induced by TLR4 
activation. The results from this part indicate a direct link between TLR and Wnt 
signaling. TLR agonists affected Wnt-related genes, while activating Wnt signaling also 
influenced LPS (TLR4 agonist)-induced NO release. 
  
Fig. 4.5.3: Effects of Wnt signaling on the LPS-induced NO release.  
106 microglial cells were seeded on a six-well plate and stimulated 
with LPS (100 ng/ml) and SB-216763 (10 µM) for 24 h. LPS (100 
ng/ml) served as a positive control for the effect of Wnt signaling 
activation on LPS-induced NO release. The effect of SB-216763 on 
LPS-induced NO release was observed when samples were pretreated 
for 4 h and then stimulated with LPS for another 24 h (see Materials 
and Methods, 3.19 for details). Data represent mean ± SEM with n ≥ 6 
(**p < 0.01 compared to the LPS-treated group).      
-
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5. Discussion 
 
5.1 Organotypic brain slice-tumor cell coculture is an effective platform 
for investigating carcinoma cell colonization of brain tissue 
 
Metastasis is the major cause of all cancer deaths. The vital role that microglial cells play 
in the CNS is well-known (Hanisch and Kettenmann, 2007). Although there is increasing 
evidence that tumor-associated macrophages support tumor progression, it is not clear 
whether resident macrophages play a role in metastasis formation as well. As of yet, 
there is no well-established marker to distinguish resident microglia from invading 
monocytes, since these share many properties (Kettenmann et al., 2011) and it remains 
unclear whether various assays to distinguish these populations correctly identify 
separate cohorts (Mildner et al., 2007; Watters et al., 2005). Though intracerebral 
injection of carcinoma cells allows for investigating tumor progression, it cannot tell 
much as to whether the surrounded macrophage-like cells originate from the brain-
resident microglia population or from bone marrow-derived peripheral 
monocytes/macrophages (Charles et al., 2011). The team of Kettenmann introduced an 
organotypic brain slice model that involved inoculating glioma cells into brain slices with 
a micromanipulator (Markovic et al., 2005). However, primary malignant gliomas differ 
in many regards from metastatic carcinomas. Malignant gliomas are of mesenchymal 
origin, do not metastasize outside the nervous system, and migrate/invade as single cells 
with no border between tumor and brain tissue. By contrast, infiltrative growth is a 
typical pathological characteristic, and such carcinomas usually migrate/invade as 
cohorts. Carcinomas often try to rebuild epithelial structures in the brain, while glial cells 
try to separate the tumor from the brain tissue by a (pseudo) capsule. Considering 
biological and morphological features, malignant glioma and metastasis of carcinomas 
are not really comparable.  
For these reasons, we modified and developed a coculture system where we do 
not inject but cocultivate a carcinoma cell plug adjacent to the brain slice. Because of the 
missing blood perfusion, there are only resident macrophages in the coculture system. 
This system allows direct cell-to-cell contact between epithelial tumor cells and brain-
derived cells, especially microglia. Since four to five slices can be obtained from each 
mouse, we can use fewer animals for our experiments and, when we think about 
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the ethical issues, the mice do not need to suffer for a long period of metastatic disease. 
Moreover, the brain slices are viable for five days or even longer, and the number of 
apoptotic cells did not significantly increase over time, confirming that this model can be 
used for several days without deleterious effects to the brain slices. The modification 
with a metallic spacer to place the tumor cell plug offered us a reproducible model to 
evaluate the grade of tumor invasion afterwards. Most importantly, there was, indeed, 
measurable tumor cell invasion into the brain slice. Additionally, when we compared 
slices from different sections or cocultured tumor cells at different cortical regions of the 
brain, the tumor cell invasion was consistent without significant differences, i.e. 
independent of the used brain sections or cortical regions. Since there are no T cells and, 
therefore, no allo-reactivity, this further enables the use of even human cancer cells in 
coculture experiments with immunocompetent mice strains or knockout mice. By many 
aspects, the brain slice coculture model is thus reliable and reproducible and comes with 
many advantages. The cancer cells invade into the brain slice, which is comparable to the 
real in vivo situation. Microglia and astrocytes accumulate at the border of the tumor plug, 
meaning that microglia enter the tumor plug, and tumor cells invade the glia scar. This is 
comparable to an observation made by Baumert and colleagues, who found an infiltration 
zone in 63% of autopsy cases with brain metastases (Baumert et al., 2006).  
This new model is an easy alternative to previous techniques and seems to be 
appropriate for studying cell-to-cell interaction. Time-lapse imaging over an extended 
period of time not only revealed the viability of the slice but also offered a good platform 
to observe the cellular interactions. Using cell surface ILB4-Alexa Fluor 568 staining to 
trace microglial cells, we observed the heterogeneity of microglial cells in the new 
coculture system when interacting with tumor cells. This allowed us to identify microglia 
that interact with single tumor cells or tumor cell cohorts. Microglial cells can even 
establish contact with each other by extending protrusions of up to 500 µm. In some 
cases, microglia served as transporters, helping a single cancer cell to move from one 
microglia to another until reaching the edge of the slice. Individual images from time-
lapse microscopy show the various morphologies of microglia, most likely as an 
adaptation to changes in the microenvironment. This brain slice coculture model has a 
strong potential for a wide variety of applications. However, there are still some 
limitations with this method. First, this coculture model is only suitable for the 
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investigating colonization, and cannot be used to investigate the whole process of tumor 
invasion—in particular the extravasation. Second, because of the missing circulation, we 
are unable to see the peripheral circulation effect in tumor progression or the effects of 
blood-derived cells like T cells or B cells.  
 
5.2 Clodronate efficiently depletes microglia, which reduces tumor 
invasiveness 
 
Interestingly, all the major target organs of metastasis possess tissue-specific macrophage 
populations. Indeed, Kupffer cells and bone marrow-derived macrophages have been 
shown to exert both tumoricidal and prometastatic effects (Gjoen et al., 1989; Gorden et 
al., 2007; Heuff et al., 1995; Sturm et al., 2003). Brain metastasis shows typically 
infiltration by microglia, but also by macrophages (Shinonaga et al., 1988) . To really 
characterize the effects of the resident microglia in brain metastasis, we first investigated 
the effects of microglia in non-contact Boyden chamber assays. There, microglia 
significantly induced tumor migration, suggestive of supported invasion.  In the new 
coculture model with direct cell-to-cell interaction, microglia invaded the tumor cell plug 
and served as guiding rails or transporters for the tumor cells. To investigate the extent of 
migrolia-assisted invasion in the coculture system, we depleted microglia by applying a 
bisphosphonate. Bisphosphonates are used to treat osteoporosis by inducing apoptosis of 
osteoclasts (Benford et al., 2001), which represent a special variety of resident 
macrophages. In other studies with cultured brain slices, clodronate proved already as an 
efficient tool for depleting microglia (Markovic et al., 2005). First we measured the 
efficiency of the depletion by analyzing the microglia markers F4/80 and CSF1R. In 
contrast to the downregulation of the microglial markers, we did not observe any 
measurable cytotoxic effects of clodronate on astrocytic or tumor cells, indicating that 
the depletion was selective for microglia. Time-lapse images with live staining for 
microglia underlined the effective depletion. This resulted in less tumor invasion and 
colonization of the brain slices. 
Our results showed that clodronate selectively inactivated microglia with severe 
effects on the capacity of cancer cell invasion. These results strongly support the 
hypothesis that microglia play a crucial role in the invasion and colonization of brain 
tissue by epithelial cancer cells. Previous data identified important signaling pathways in 
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TAM as being responsible for the tumor promoting effect. Clodronate affects several of 
these pathways in microglia. For example, clodronate significantly down-regulates the 
LPS-stimulated secretion of TNFα, IL-1β and NO in isolated microglia (Dehghani et al., 
2004). We also observed a down-regulation of Wnt5a and CXCR4 gene expression in 
microglia treated with clodronate (data not shown). Zoledronate, a compound related to 
clodronate, has been shown not only to prevent skeletal fractures in breast cancer patients 
but also to prevent skeletal metastasis and metastasis in other organs (Gnant, 2009). This 
effect could result from cytotoxic effects on the tumor cells, or it could be related to 
inhibition of blood-derived or resident macrophages in the tumor stroma. However, to 
apply this to brain metastases, further pharmacological modification would be needed 
due to the difficulties for some compounds to cross the BBB. 
 
5.3 Microglia and astrocytes show an effective defense against 
immortalized non-cancerous cells in contrast to carcinoma cells 
 
Microglia serve as the first line of defense against infection and respond to any kind of 
homoeostatic disturbance in the brain. Accordingly, they are found to be activated in 
virtually all CNS diseases (Hanisch and Kettenmann, 2007). Whether they are beneficial 
or harmful depends on the context (Schwartz et al., 2006). The infiltration of 
microglia/macrophages in conjunction with brain metastasis can be observed in clinical 
patients and results in poor prognosis (Lin and Pollard, 2004).  
In the present work, immortalized, non-cancerous MDCK cells showed 
significantly less colonization of brain tissue than MCF-7 cells. At least partially, this 
was due to the fact that stromal cells killed most MDCK cells that had direct contact with 
brain slices. This indicates an intact defense function of stromal cells against foreign 
antigens in this context. However, stromal cells did not kill tumor cells. On the contrary, 
microglia even fostered the invasion of tumor cells. Obviously, cancer cells had escaped 
immune surveillance and were able to form a permissive and supportive environment by 
exploiting adjacent stromal cells, for example to promote angiogenesis via secretion of 
VEGF, other cyto- and chemokines, and MMPs (Mueller, 2004). 
A time-lapse video (see video 2) shows that microglia escaped from the slice and 
pulled or guided malignant cells into the tissue. At first, microglia meeting MDCK or 
MCF-7 cells showed no difference. Upon physical contact, however, the benign cells 
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were killed as expected, while malignant cells survived and even stimulated microglia 
into adopting a tumor-promoting phenotype and helping the cancer cells to invade the 
brain slice. Stromal cells exhibited discriminatory defenses between immortalized non-
cancerous and tumor cells. Tumor cells successfully dodged the defenses and turned 
them into a sort of guiding track to help them invade the brain slice. Microglia that had 
moved out of the brain slice served to transport malignant cells into the brain slice, which 
then moved ever deeper along the microglia trail. Microglia seem not only to have played 
a role in guiding malignant cells, but also in preparing for colonization. To our 
knowledge, this is the first study to document the heterogeneity and plasticity of 
microglia in this regard. 
Although this thesis focuses on the role of microglia, it is possible that other 
stromal cells play a role in CNS homeostasis or brain metastasis. Astrocytes, for 
example, are a potential candidate. Although the classic role of astrocytes is to provide 
neurons with energy and substrates for neurotransmission, an increasing body of 
evidence points to other roles. Astrocytes provide nourishment to neurons, notably 
lactate. When the CNS system encounters dangers, however, astrocytes clean up the 
damaged cells via phagocytosis and even form a glia scar, which serves as a barrier to the 
regeneration of damaged axons (al-Ali and al-Hussain, 1996; Allen and Barres, 2009; 
Fawcett and Asher, 1999). Although astrocytes are less efficient in removing apoptotic 
lymphocytes than microglia, both of them are capable of ingesting apoptotic cells 
(Magnus et al., 2002). Astrocytes can modulate microglial and macrophage phagocytotic 
ability (DeWitt et al., 1998; Smith and Hoerner, 2000).   
Recent research has revealed their role in tumor invasion. Scanning electron 
microscopy has shown that astrocytes can form direct contact with tumor cells via their 
multiple podia (Kim et al., 2011). Fidler and colleagues recently demonstrated that tumor 
cells can exploit astrocytes, for example to avoid chemotherapy-induced apoptosis. This 
effect has been observed in various human cells, including melanoma cells, breast cancer 
cells and lung cancer cells (Fidler, 2011; Kim et al., 2011; Lin et al., 2010a). This offers 
new insight into the role of stromal cells in immune defenses and tumor invasion.  
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5.4 Microglia-assisted invasion of breast cancer cells relies on Wnt 
signaling 
 
Wnt signaling plays an important role in cancer development. Activating Wnt signaling 
contributes to tumor proliferation, angiogenesis, invasion and metastasis. To date, little is 
known about Wnt signaling in metastasis, in particular in brain metastasis. Most research 
focuses on the Wnt effect in primary tumors and tumor initiation. What we know so far is 
that Wnt signaling is relevant for brain metastasis. Some human breast carcinomas 
express high levels of Wnt2, Wnt5a and Wnt7b (Brown, 2001), and clinical studies have 
shown the significance of Wnt signaling in the formation of breast cancer brain 
metastasis (Smid et al., 2008). Smid and colleagues found Wnt signaling pathways over-
expressed in the basal-like subtype and in primary breast cancers, that later relapse to the 
brain or bone. Several Wnt-related genes, including sFRP1, Fz6, Fz7, β-catenin and 
TCF7, are up-regulated in relapse patients, while the APC gene is down-regulated (Smid 
et al., 2008). Inhibiting Wnt signaling may reduce tumor cell proliferation and metastasis 
(Hirata et al., 2011; Saini et al., 2009). Previous research has identified the Wnt/TCF 
target genes homeobox protein-B9 (HOXB9) and LEF1 as mediators allowing lung 
adenocarcinoma cells to colonize the brain and bones, indicating a key role in tumor 
colonization (Nguyen et al., 2009). β-catenin mutation has been observed in primary 
brain tumors, but was not found in a patient with lung metastasis to the brain (Lee CI, 
2009). In contrast, in previous research by our group, breast cancer metastases tested 
negative for nuclear β-catenin staining, but exhibited strong nuclear staining for c-Jun. In 
addition, the expression of Wnt5a and Wnt5b was high in metastasis samples, whereas 
expression of Wnt3a and E-Cadherin was low compared to that in weakly invasive tumor 
cells (Klemm et al., 2011). All of this indicates that Wnt signaling plays a key role in 
tumor colonization or metastasis to the brain.  
Our microarray data indicate that more than 400 genes were regulated in LPS-
instructed microglia ± coculture with MCF-7 cells. Further pathway analysis of these 400 
genes using the Panther database (www.pantherdb.org) confirmed that Wnt signaling was 
among the five most regulated pathways. We proved the importance of Wnt signaling in 
microglia-induced tumor invasion by applying recombinant Wnt antagonists, DKK1 or 
DKK2, as well as secreted frizzled-related protein in different invasion assays, which 
resulted in less tumor invasion and colonization of brain tissues. In particular, DKK2 
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almost completely inhibited microglia-induced tumor invasion not only in indirect cell-
to-cell contact cocultures, but also in the direct brain slice-tumor cell coculture. With 
qRT-PCR techniques, we identified endogenous gene expression of Wnt in microglial 
cells. Among the Wnt-related genes we tested, expression of Wnt5a, Wnt6 and DKK2 
was most prominent. Microglial cells express Wnt5a constitutively, and this is 
independent of the tumor cell coculture. Although microglial cells do not up-regulate 
Wnt5a gene expression as TAMs in microglia-induced tumor invasion (Pukrop et al., 
2006), Wnt5a plays an important role in this process. This was shown in cocultures of 
tumor cells and brain slices from heterozygous Wnt5a-deficient mice, the tumor invasion 
was significantly reduced. This confirms the role of Wnt signaling, in particular, it 
indicates that Wnt5a is essential for tumor cells to invade and colonize brain tissue.    
To date, our knowledge of Wnt signaling in tumor progression comes from 
observing the direct effects of Wnt in tumor cells. However, we should not neglect the 
role of Wnt signaling in the cells interacting with the tumor cells, namely the 
macrophages, or other immune cells. Our research team has previously found that Wnt5a 
was up-regulated in macrophages when cocultured with tumor cells, and that this Wnt-
induced tumor invasion can be antagonized by rDKK1 (Pukrop et al., 2006). Ojalvo et al. 
also found an increase of Wnt5b and Wnt7b in invasive TAMs compared to general 
TAMs (Ojalvo et al., 2010). In addition, Ghosh and colleagues demonstrated that 
CXCR4 is a target of Wnt5a in T-cells, which regulates directional-migration mediated 
by SDF-1 (Ghosh et al., 2009). However, it has also been shown that Wnt5a from tumor 
stromal cells can induce differentiation of basal cell carcinomas via Wnt/Ca
2+
-dependent 
pathway (Nitzki et al., 2010). All of these studies point to a key role of Wnt, especially 
Wnt5a signaling in tumor-associated immune cells.  
In this thesis, we could underline the importance of Wnt signaling for our 
observed effects using the Wnt inhibitors DKK1 and 2. Application of these two proteins 
to our direct brain slice-tumor cell coculture resulted in a different outcome regarding 
tumor cell invasion. Considering their protein structure, DKK1 and DKK2 are highly 
similar, sharing a 50-70% identity in the N- and C-terminal cysteine-rich region. Despite 
the high degree of structural similarity, DKK1 and DKK2 exhibit distinct biological 
properties. The DKK family comprises four members (DKK1 to DKK4) and a unique 
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DKK3-related protein named Soggy (Sgy). DKK1 and DKK2 are the most intensively 
studied members of the DKK family. 
In adult tissues, DKK1 is expressed in the placenta, colon, spleen and prostate. 
DKK2 transcripts take place in the heart, brain, skeletal muscles and lungs (Diep et al., 
2004). One of the most obvious differences is that mice deficient in DKK1 are 
embryonically lethal, while DKK2-deficient mice are viable and fertile without grossly 
abnormal phenotypes (Li et al., 2005; Mukhopadhyay et al., 2001). Reducing the 
expression of DKK1 affects head development (MacDonald et al., 2004), while the 
function of DKK2 remains poorly defined. In the literature, DKK1and DKK4 are known 
to have Wnt-inhibitory effects, while DKK2 serves either as a Wnt inhibitor or activator 
(Niehrs, 2006). The activating effect of DKK2 is blocked by DKK1 (Wu et al., 2000).  
The best known action of DKKs is to antagonize Wnt/β-catenin signaling by 
binding to the coreceptors LRP5/6. However, effects on β-catenin-independent signaling 
have also been observed. What we know so far about the role of DKK2 is that it affects 
eye development and osteoblast gene expression. DKK2 deficiency leads to osteopenia 
(Gage et al., 2008; Li et al., 2005). In the present work, among all tested Wnt-related 
genes, DKK2 exhibited the strongest expression in microglia. This indicates that DKK2 
may play a more important role in brain homeostasis than DKK1. The regulatory effect 
of DKKs on Wnt signaling depends on the cellular context, which modulates their effects 
(Brott and Sokol, 2002).  
 
5.5 CXCR4 is a target of Wnt signaling and plays an important role in 
microglia-induced invasion 
 
CXCR4 is a seven-span transmembrane G-protein-coupled receptor (GPCR), known to 
be a chemokine receptor, with its specific ligand, SDF-1. CXCR4 also serves as a co-
receptor for entry of HIV, which targets CD4
+
 T cells (Sun et al., 2010).  Higher levels of 
CXCR4 expression correlate with an advanced stage of cancer and metastasis, while 
overall survival rates negatively correlate with CXCR4 expression (Wang et al., 2008). 
To answer the question of whether CXCR4 is necessary for microglia-assisted tumor cell 
invasion, we first performed microarrays. Our whole genome array showed that CXCR4 
was an interesting candidate to regulate microglia-induced invasion. Notably, the 
CXCR4 gene, which is known to be a target of Wnt5a, was the most strongly regulated 
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gene (more than 32-fold), when tumor cells were exposed to inflammatory microglia, 
previously activated by LPS. By using qRT-PCR, we confirmed the up-regulation of 
CXCR4 in microglia when exposed to tumor cells. Application of the CXCR4 inhibitor 
AMD3100 significantly antagonized microglia-induced invasion in Boyden chamber 
experiments. In a direct-contact coculture, AMD3100 also inhibited invasion of brain 
tissue by MCF-7 cells without cytotoxic effects either to the tumor cells or the microglia. 
This indicates that CXCR4 plays a key role in tumor colonization or metastasis to the 
brain.    
To determine if there is any crosstalk between CXCR4 and Wnt signaling, we 
applied the Wnt antagonists rDKK1 and rDKK2, which subsequently down-regulated 
CXCR4 gene expression in tumor-instructed microglial cells, but not in tumor cells. 
These data support previous findings that Wnt regulates CXCR4 in the immune system 
and stromal cells. Ghosh and colleagues have recently shown that Wnt5a is an important 
mediator for CXCR4-induced T-cell migration and promotes cell polarity and directional 
movement of melanoma cells in an SDF-1 gradient (Ghosh et al., 2009). However, when 
we measured the protein expression, no measurable change could be detected. In addition 
to the possibility that the measuring system we used was not sensitive enough, another 
explanation could be that the change in CXCR4 gene expression influences tumor 
invasion by regulating other genes or by producing a paracrine effect on other cells.  
As shown in the literature, both Wnt3a and the GSK-3ß inhibitor, LiCl  result in 
down-regulation of SDF-1 in stromal cells (Wang et al., 2008). On the other hand, SDF-1 
stabilizes and increases translocation of β-catenin into the nucleus of rat neural 
progenitors (Luo et al., 2006). Microarray data indicate that SDF-1 accumulation can 
enhance expression of genes that are known as targets of β-catenin/TCF/LEF, such as 
cyclin D1 and c-myc (Luo et al., 2006). In migrating cells, Wnt/β-catenin signaling in the 
leading ones confers coordinated collective migration, which is a hallmark of embryonic 
morphogenesis and cancer metastasis via CXCR4b and CXCR7b regulation (Aman and 
Piotrowski, 2008). Cancer metastasis via CXCR4b and CXCR7b regulation is in line 
with the reported activation of the SDF-1/CXCR4 axis in the tip cells of collectively 
migrating cancer cells (Friedl and Gilmour, 2009).  Our own previous results and other 
previously published studies underline a link between Wnt signaling and CXCR4. We 
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have also demonstrated the importance of CXCR4 gene expression in microglial cells, 
with implications for a further influence on tumor invasion and colonization.  
 
5.6 TLR4 signaling in tumor progression 
 
As mentioned above, the whole genome analysis of LPS-instructed microglia ± coculture 
with MCF-7 cells revealed more than 400 differentially regulated genes. Pathway 
analysis of these genes shows an enrichment of the inflammatory chemo-/cytokine and 
Wnt pathway. Coincidently, the inflammatory ―back shift‖ reduced the proinvasive 
functions of microglia. Recently it was shown that LPS induces cancer-inhibiting activity 
against glioma cell lines by triggering autophagy-dependent death in glioma cells (Mora 
and Regnier-Vigouroux, 2009). In our case, we observed no influence of LPS on tumor 
cell viability and other malignant features or any cytotoxicity to the microglia. In the 
literature, there are also reports about the influence on the glioma microenvironment. In 
experiments with intra-tumoral applications of LPS in mice implanted with glioblastoma 
cells, LPS also increased their survival time, but the protective effect was diminished in a 
TLR4-deficient microenvironment (Charles et al., 2011; Chicoine et al., 2007). Thus we 
investigated the influence of LPS/TLR4 activation in the context of microglia-induced 
carcinoma cell invasion.  Our study found out that LPS decreased microglia-induced 
tumor invasion, while another TLR antagonist, Pam3CSK4, did not. This specific anti-
invasive effect of LPS was again confirmed in direct-contact organotypic brain slice 
coculture. The results were identical for human and mouse breast cancer cell lines. 
Pam3CSK4 activates TLR1/2 and signals solely via the MyD88-dependent pathway. LPS 
activates TLR4 and signals in a MyD88- and TRIF-dependent way—a fact that is unique 
among the TLRs. This indicates that two adaptors in TLR signaling, MyD88 and TRIF, 
may regulate tumor progression via different mechanisms. We will discuss this in the 
following paragraph.   
 
5.7 Two adaptors of TLR4 signaling, MyD88 and TRIF, seem to have 
different functions in tumor progression 
 
A variety of cells can express TLR4, including epithelial cells, macrophages, B cells and 
fibroblasts (Akira et al., 2006). There is increasing evidence that TLR signaling is 
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important in tumor initiation. Silencing TLR4 signaling in tumor cells can inhibit tumor 
formation (Earl et al., 2009). Previous research indicates that TLRs in tumor cells allow 
them to evade immune surveillance (Huang et al., 2005).  High expression of 
TLR4/MyD88 signals correlates with a poor prognosis for CRC patients (Wang et al., 
2010) and a MyD88 deficiency in a sporadic mouse model for colon cancer reduced 
tumor formation (Rakoff-Nahoum and Medzhitov, 2007).  This latter effect might occur 
via regulation of the tumor modifier MMP7, which is expressed only in dysplastic 
epithelial cells, or cyclooxygenase-2 (COX-2), which is expressed in a variety of cells, 
including fibroblasts and macrophages. Altogether, these studies indicate the importance 
of MyD88 in tumor initiation and eventually in tumor progression, and partially link the 
effects to the microenvironment. 
We demonstrated that TLR4-deficient microenvironments reduced invasion and 
colonization of breast cancer cells into brain tissues, indicating that microenvironmental 
TLR4 signaling plays an important role in microglia-assisted invasion. Since TLR4 
signals via both adaptors MyD88 and TRIF, we next investigated their roles in this 
process. First we used microglia or brain slices that were deficient in either of the two 
adaptors. Microglia isolated from MyD88-deficient mice significantly reduced microglia-
induced invasion by MCF-7 cells. MyD88-deficient brain slices again reduced invasion 
compared to wildtype mice. Furthermore, adding microglia from the wildtype strain into 
the tumor plug in coculture with MyD88-deficient brain slices rescued the anti-invasive 
effect of the tissue deficiency. These results suggest that the presence of MyD88 in the 
microenvironment (in particular, in microglial cells) plays an important role in microglia-
assisted invasion. 
Other studies also found that TLR2 or MyD88 played a role in promoting 
metastasis (Hagemann et al., 2008; Kim et al., 2009). Kim and colleagues found small 
clusters of Lewis lung carcinoma (LLC) cells with adjacent CD11b
+
 and CD11c
+
 
myeloid cells after injecting the cancer cells into the tail vain. This formation of the 
metastatic niche was diminished in TLR2
-/-
 mice. TLR2 only signals via MyD88 and, 
therefore, supports our findings concerning the pro-metastatic effect of MyD88. Other 
results also demonstrated that MyD88 signaling in macrophages is responsible for 
metastasis in an ovarian cancer model (Hagemann et al., 2008).  
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Since we demonstrated that the adaptor MyD88 is necessary for tumor invasion, 
we speculated that the adaptor TRIF causes the protective effects of TLR4 activation by 
LPS. When we began this study, little or nothing was known about the role of the adaptor 
TRIF in tumor progression. Most TLR signaling research in cancer focused on MyD88, 
and this is still in the early stages of exploration. Only TLR3 and TLR4 activate the 
adaptor TRIF and lead to a specific cytokine/chemokine release. IFNβ is a major and one 
of the most studied TRIF targets in this case. 
As expected, the degree of MCF-7 invasiveness for TRIF-deficient brain slices 
did not differ from those of wildtype mice, but the protective effect of LPS was 
eliminated. Again, adding microglia from wildtype strains into the tumor plug rescued 
this protective effect. This confirms our hypothesis that TRIF is involved in the 
protective effect of LPS, in particular in microglial cells.  
 
Fig. 5.7: Hypothetical model: Two 
adaptors of TLR4 signaling, MyD88 
and TRIF, have different functions in 
tumor progression. MyD88 plays a 
crucial role in tumor invasion, while TRIF 
is important for the protective LPS effect.  
 
 
 
 
 
 
 
 
5.8 Either TRIF signaling or IFNβ alone is insufficient to reduce tumor 
invasion 
 
We demonstrated that the anti-invasive effects of LPS seemed to rely on TRIF-dependent 
pathways in microglia. The most important target of TRIF pathways is IFNβ. IFNα and 
IFNβ are type I IFNs, which have antiviral characteristics and play an important role in 
the immune system by activating a variety of cells, including dendritic cells, cytotoxic T 
cells, natural killer cells and monocytes. IFNβ is an established treatment in multiple 
sclerosis patients, but its effects on tumor progression remain controversial. Preclinical 
progression. 
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evaluations have shown that human IFNβ treatment in combination with tamoxifen can 
induce apoptosis in many human breast cancer cells, both ER-positive and ER-negative, 
and ovarian cancer cell lines (Lindner and Borden, 1997). High doses of recombinant 
human IFNs can induce apoptosis of ovarian cancer cells in 24 h, while lower doses 
require 3-4 days (Markman et al., 2004). The review paper from Wang has shown that 
IFNβ exhibits antiproliferative activity and apoptotic effects to melanoma, leukemia and 
renal cell carcinoma cells  (Wang et al., 2011). Qin et al. found that human IFNβ gene 
therapy blocks the formation of breast tumors and causes regression of established 
tumors in immune-deficient mice (Qin et al., 1998). Other research indicates that the 
anti-tumor mechanisms of human and mouse IFNβ gene therapy differ in mouse models. 
Qin found that human IFNβ significantly reduces cell viability at 100 U/ml in xenograft 
tumors, whereas mouse IFNβ did not produce any anti-proliferative activity, even at a 
concentration of up to 30,000 U/ml. The missing cross-species activity indicates that the 
activation of the murine tumor microenvironment by mouse IFNβ was ineffective in 
combating xenograft tumor formation (Qin et al., 2001). Our experiments also found that 
applying 100 ng/ml of mouse IFNβ to organotypic brain slice cocultures did not produce 
a significant difference in tumor invasion. Thus, IFNβ alone does not execute the 
reduction of microglia-assisted tumor invasion. Our in vitro effects underline the 
disappointing data from clinical trials with IFN proteins of solid tumors (Studeny et al., 
2004; Yoshida et al., 2004). Several scientists speculate that these disappointing results 
may be due to the particularly short half-life of IFNβ, which ranges from a few minutes 
to a few hours, but this argument cannot apply to our model.  
Because of this result, we wanted to know whether TRIF activation alone is 
sufficient to mimic the protective effect. In the TLR family, TLR3 signals only via TRIF. 
The anti-viral effects of TLR3 activation are well-known (Matsumoto and Seya, 2008), 
but its role in tumor progression remains largely unknown. Salaun et al. showed that a 
TLR3 agonistic dsRNA, poly (I:C), induces apoptosis of some human breast cancer cells 
(Salaun et al., 2006). The TLR3 agonist in combination with either type I IFN or protein 
synthesis inhibitors mediated apoptosis in human melanoma cells (Salaun et al., 2007). In 
contrast, a TLR3 inhibitor, phenylmethimazole (C10), significantly inhibits the growth of 
melanoma and pancreatic cancer cells (Schwartz et al., 2009). The effects of TLR3 
activation in the tumor microenvironment have not been investigated before, and we, 
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therefore, used poly (A:U), a double-stranded RNA that serves as an effective agonist for 
activating TLR3 signaling (Conforti et al., 2010). The treatment with 100 µg/ml of poly 
(A:U) again did not reduce microglia-assisted tumor invasion (Fig. 4.4.6). These results 
demonstrate that activating TRIF signaling alone is not sufficient to achieve a protective 
effect. This is in line with recent studies in which poly (A:U) alone did not trigger potent 
immunoadjuvant effects; only in combination with vaccines and chemotherapy did it 
trigger a T cell-dependent anti-tumor effect (Conforti et al., 2010). However, TLR3 may 
also contribute to tumorigenesis by inducing CCL5 and CXCL10. Conforti et al. have 
shown that CCL5 and CXCL10 could be beneficial or harmful (Conforti et al., 2010). 
Based on the data and conclusions from other research, we speculated that the 
protective effect of LPS seems to be less a qualitative one (only TRIF-related) than a 
quantitative one (balance of both TRIF and MyD88). Though a MyD88 signal alone is 
sufficient for the pro-metastatic effect, the protection seems to be related to both 
adaptors, MyD88 and TRIF, with a polarization towards TRIF. This suggests the 
existence of common targets of both adaptors as playing a role in our context. 
 
5.9 NO as a common target of TRIF and MyD88 in microglia-assisted 
invasion 
 
Based on the literature, we identified NO to be an interesting candidate because data 
showed regulation by TRIF as well as NFĸB, an effector of the MyD88 as well as TRIF 
pathways (Tumurkhuu et al., 2010). NO is a diffusible free radical with a role in 
vasodilation. It is synthesized from L-arginine, NADPH and oxygen by the NO synthase 
(NOS), which comprises three isoforms, i.e. iNOS, neural NOS (nNOS) and endothelial 
NOS (eNOS). Several studies found that NO is up-regulated in many tumors, which has 
drawn attention to its role in tumor growth, angiogenesis, migration and metastasis 
(Muntane and la Mata, 2010; Wang et al., 2005).  
For this reason, we examined the release of NO in microglia after TLR1/2 
(MyD88-dependent), TLR3 (only TRIF-dependent) and TLR4 (both MyD88- and TRIF-
dependent) stimulation. Only the latter induced a measurable increase in NO production. 
This indicated that both adaptors would indeed, control NO release. Furthermore, using 
TRIF- or MyD88-deficient microglia reduced the effect of LPS both on iNOS gene 
expression and NO release. Although TRIF contributed more than MyD88 to iNOS 
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mRNA synthesis, MyD88 was necessary for a significant increase in the NO release. 
With these experiments, we confirmed that iNOS and the NO release fulfill the criteria of 
a common target of both adaptors, and further investigations about NO in microglia-
assisted invasion seemed promising. We, therefore, used an NO inhibitor, L-NAME, and 
an NO donor, SNAP, to test the effects of low and high NO concentrations. Surprisingly, 
both L-NAME and SNAP significantly reduced tumor invasion without cytotoxic effects 
to the microglia. These paradoxical results are also described in the literature. Promoting 
and inhibiting NO have both shown promising results for preventing tumor progression 
and metastasis (Fukumura et al., 2006; Lancaster and Xie, 2006; Orucevic et al., 1999). 
Comparable to our results, Weiss et al. showed that NO plays a biphasic role in 
macrophages in tumor progression (Weiss et al., 2010). Applying L-NAME to create low 
NO concentrations inhibited tumor growth, while applying an NO donor increased 
survival rates. High levels of NO established a polarized tumor microenvironment in 
which the macrophages displayed a classical M1 phenotype, but it also affected the 
tumor cells directly. In our experiments, SNAP treatment increased the number of 
apoptotic tumor cells in the brain slice, but not in the tumor plug, and reduced the 
metabolic activity of the cancer cells in an MTT-assay. Thus, to rule out the possibility 
that our findings only reflect a toxic effect of high NO, we performed experiments with 
one of the major downstream effectors of NO, cGMP. NO binds to the sGC and catalyzes 
cGMP, then cGMP activates the PKG (Muntane and la Mata, 2010). cGMP-independent 
NO pathways catalyze cysteine and tyrosine residues to form more stable nitrosothiols 
via S-nitrosylation. This then alters protein function and gene transcription, as well as 
cell cycle check points and DNA repair (Muntane and la Mata, 2010). In order to 
understand the role of high NO concentrations, we first used a membrane-permeable 
analog of the natural cGMP signal molecule, 8-Br-cGMP, which resulted in less tumor 
invasion and confirmed the SNAP data without toxic effects on the cancer cells. A 
previous study that supports our finding also found that NO inhibits cancer cell invasion 
via a cGMP-dependent pathway (Postovit et al., 2002). 
 
5.10 Crosstalk between Wnt signaling and TLR signaling pathways 
 
Previous studies indicate that Wnt and TLR signaling pathways play important roles in 
tumor invasion (Giles et al., 2003; Wolska et al., 2009). In our study, we found that Wnt 
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and TLR-related genes directly affected microglia-induced and microglia-assisted tumor 
invasion and colonization of brain tissues. Whether there is a link between these 
important pathways is not well understood. Previous studies also support the idea of 
crosstalk between TLR4 and Wnt5a signaling. Blumenthal and colleagues found that 
activating TLR4 signaling in human macrophages induces Wnt5a expression 
(Blumenthal et al., 2006). In human and murine artherosclerotic lesions, TLR4 and 
Wnt5a expression colocalizes in macrophage-rich regions and LPS induces Wnt5a 
mRNA expression (Christman et al., 2008). Wnt5a triggers the Wnt/Ca
2+
 pathway, which 
activates the central inflammatory transcription factor NF-ĸB (Bradley and Drissi, 2010; 
Sen and Ghosh, 2008). Pereira et al. also found that Wnt5a is up-regulated in sepsis 
patients and confirmed that Wnt5a induces proinflammatory cytokines in human 
monocytes (Pereira et al., 2008). 
From our whole genome results of LPS, we showed an influence on several Wnt 
genes. RT-PCR assays further confirmed this by showing that TLR activation led to a 
gene regulation of Wnt5b, Wnt6 and DKK2 in microglia.  Furthermore, these regulatory 
effects were related to the adaptors TRIF and MyD88, as we observed a decrease in the 
regulatory effects in TRIF- or MyD88-deficient mice of all three candidates. In addition, 
the Wnt5a target gene CXCR4 was also affected by LPS, and seems to be regulated by 
both adaptors TRIF and MyD88, whereas MyD88 seems to be more important. While 
TLR signaling influences Wnt signaling, we also found that Wnt signaling influences 
LPS-induced NO expression. We used SB-216763 to antagonize GSK-3, which plays an 
important role in Wnt signaling. Although SB-216763 boosted the release of NO, it 
down-regulated LPS-induced NO release significantly. This confirmed that Wnt 
signaling also plays an important role in the TLR4-induced effects of NO. These results 
are in line with those of a research team led by Yuskaitis, who demonstrated that GSK-3 
inhibitors protect microglia from inflammation-induced neurotoxicity and showed that 
inhibitors of GSK-3 greatly reduce LPS-induced IL-6 and NO production (Yuskaitis and 
Jope, 2009). Pereira also showed that LPS/IFN and Wnt5a phosphorylate CaMKII and 
the Wnt antagonist sFRP-1 reduces this phosphorylation (Pereira et al., 2008). There is 
also increasing evidence that Wnt has a pro- and anti-inflammatory role and that different 
Wnts may effectively cross-regulate each other (Manicassamy et al., 2010; Schaale et al., 
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2011). Additionally, Schaale provides some new evidence of crosstalk between Wnt and 
TLR/NF-B signaling. 
Our results also indicate a direct link between TLR and Wnt signaling. TLR 
agonists affect Wnt-related genes, while activating Wnt signaling also influences TLR 
signaling. That means that, besides embryonic development, tissue homeostasis, tumor 
initiation and progression, Wnt signaling is also part of the inflammatory network and 
involved in the regulation of acute and chronic inflammation.     
 
5.11 Clinical applications 
 
Increasing evidence indicates that microglia/macrophages play important roles in 
metastasis and seem to be potential targets for cancer therapy. Bisphosphonates, which 
can effectively inactivate microglia/macrophages, are well-established therapeutics with 
particular potential. In several studies, primary breast cancer patients treated with 
bisphosphonate showed lower skeletal morbidity and bone metastasis than control groups 
(Brown and Coleman, 2002). Our exciting findings may point to a role for 
bisphosphonates in fighting tumor progression by inhibiting the blood-derived or resident 
macrophages in the tumor microenvironment.  
High proportions of different human cancer types express CXCR4, and 
preclinical studies have highlighted the therapeutic potential of drugs that antagonize 
CXCR4 (Balkwill, 2004). AMD3100 was recently approved by the FDA in combination 
with granulocyte-colony stimulating factor (G-CSF) in patients with non-Hodgkin’s 
lymphoma and multiple myeloma (Pusic and DiPersio, 2010). Safety studies and studies 
on using plerixafor in combination with chemotherapy or G-CSF to treat acute myeloid 
leukemia are already in phase I of clinical trials (www.clinicaltrials.gov, 2011).  Our 
findings concerning the role of AMD3100 in hindering tumor colonization could point to 
a new use for this drug.  
Although preclinical data indicate that Wnt signaling plays a key role, no clinical 
data have supported this so far. Studies are still in the early phases. Resveratrol, which 
has been observed to modulate Wnt signaling, was used in phase I and phase II studies 
with colon cancer patients (Creppe et al., 2009). A Wnt-blocking drug, PRI-724 the 
biopharmaceutical company Prism Biolab, will start phase I clinical trials to investigate 
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the drug’s safety and efficacy in advanced solid tumor metastasis in 2011. Also this year, 
Novartis will lead a phase II study on the effects of BHQ880, an anti-DKK1 monoclonal 
antibody, in fighting untreated multiple myeloma (www.clinicaltrials.gov, 2011).  We 
showed that Wnt antagonists have a reducing effect, with rDKK2 in particular reducing 
tumor colonization in brain tissues. This may point to a therapeutic application by 
targeting Wnt signaling in cancer therapy, but more detailed research is needed.   
Long before TLRs were discovered, Coley hypothesized that inactivated bacteria 
components might have anti-tumor effects. Since Coley’s toxin treatment, which 
combined a heat-killed Streptococcus pyogenes and Serratia marcescens, effectively 
cured patients with inoperable tumors in 1892, it opened a window for potential cancer 
therapy. One century later, we know that Coley performed a massive TLR activation by 
injecting microbial constituents. Although the role of TLR in cancer progression is still 
poorly understood, some in vivo studies have shown promising results, especially as 
effective adjuvants for vaccination or chemotherapy  (Kawai and Akira, 2010). TLR3, 
TLR4, TLR7/8 and TLR9 are on the National Cancer Institute’s list of the most 
promising immunotherapeutic candidates (Adams, 2009; Cheever, 2008). A TLR7 
agonist, Imiquimod from the pharmaceutical company3M, has been approved by the 
FDA for basal cell carcinoma treatment. One promising candidate, monophosphoryl lipid 
A (MPL), which targets the TLR4 complex and lacks LPS toxicity from Salmonella 
minnesota, will start phase I/II clinical trials to investigate its efficiency as an adjuvant in 
melanoma and breast cancer patients. GlaxoSmithKlein also led a phase I/II study on the 
effects of MAGE A3, a tumor-specific antigen, in combination with TLR4/TLR9 agonist 
as a radiosensitizer or adjuvant in several cancers including melanoma, non-small cell 
lung cancers and so on. At the same time, however, some results indicate that TLR 
activation fosters tumor progression. Detailed and recent clinical trials for cancer therapy 
can be found in the following sources: (Adams, 2009; Makkouk and Abdelnoor, 2009; 
www.clinicaltrials.gov, 2011).  Our study explains the ambiguous role of TLR activation 
in cancer progression and opens some new therapeutic strategies. 
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6. Summary 
 
Metastasis, especially brain metastasis, is a major cause of cancer-related deaths. Despite 
this important issue, minimal scientific and therapeutic progress has been made in recent 
decades. With regard to the role of the metastatic microenvironment, our understanding 
is just at the beginning. Thus, our new coculture model offers a way to investigate the 
effects of the metastatic microenvironment. With this new technique, we were able to 
investigate the interaction between resident brain macrophages and tumor cells in a well-
defined setting. This allowed us to detect a correlation between cancer cell invasion and 
microglia accumulation at the slice border.  
Time-lapse microscopy revealed direct interactions between microglia and tumor 
cells and showed that microglia served as a guiding rail and transporter for tumor cells. 
This indicates that microglia facilitate tumor invasion. The new mechanism of tumor cell 
invasion was specific for malignant cells and not observed with immortalized epithelial 
non-cancerous cells. As a proof of principle, specific depletion of microglia by 
clodronate abolished tumor cell invasion.       
Furthermore, we identified Wnt and TLR signaling as important pathways in 
microglia-assisted invasion. The Wnt antagonists DKK1 and DKK2 reduced microglia- 
assisted invasion and expression of CXCR4, a direct target of Wnt signaling in microglial 
cells. The role of Wnt signaling was further specified by the finding that brain slice 
cocultures from Wnt5a
+/-
 deficient mice showed reduced tumor cell invasion. The target 
gene of Wnt5a, CXCR4, was also shown to be involved in this process.  
TLR signaling plays an ambiguous role with pro- and anti-invasive functions. By 
using mice deficient in TRIF, MyD88 and TLR4, we demonstrated that MyD88 signaling 
in microglia is necessary for tumor invasion and TRIF, or in its combination with 
MyD88, plays a protective role in response to LPS. The balance of these two adaptors—
in particular in microglial cells—could be a key to regulating tumor invasion or 
metastasis. NO, a common target of both adaptors, could be an interesting mediator for 
tumor invasion. We showed that NO also plays an ambiguous role. Applying either an 
NO inhibitor or an NO donor both produced anti-invasive effects, which indicates the 
biphasic role of NO in regulating tumor progression. This modulation of NO could be a 
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potential therapeutic strategy for cancer therapy, though more preclinical work would be 
needed.   
Last but not least, a link between Wnt and TLR signaling pathways was found. 
LPS, which is a TLR4 activator, can affect several Wnt genes. On the other hand, the 
inhibition of GSK-3, which is known to be a key mediator in Wnt signaling, can also 
affect the release of LPS-induced NO.   
Taken together, the results indicate that microglial cells are important for tumor 
invasion and that Wnt and TLR signaling pathways are involved in this process. TLR4 
exhibits different regulatory effects via activation of TRIF and MyD88. We also found 
evidence of interplay between the Wnt and TLR signaling pathways. These new findings 
could be most helpful in the discovery of novel and selective therapies for tumor 
treatment. 
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